Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_IHD,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.22 [1.18-1.26],6.92226216165187e-30,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LPA,Apolipoprotein(a),Inverse variance weighted,38,1.11 [1.09-1.14],6.212742080464e-19,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FURIN,Furin,Wald ratio,1,1.24 [1.14-1.34],2.03439452561948e-07,cis
Chapter IX Diseases of the circulatory system,I9_IHD,APOE,Apolipoprotein E,Inverse variance weighted,23,0.93 [0.9-0.96],6.49129666109699e-06,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.23 [1.12-1.36],3.44154363684458e-05,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.36 [1.16-1.59],0.000111849271914066,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.83 [0.76-0.92],0.000127022615325066,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.09 [1.04-1.14],0.000295517421782444,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.06 [1.02-1.09],0.00057031385526022,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EGFLAM,Pikachurin,Inverse variance weighted,19,1.04 [1.02-1.07],0.00108875237730486,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.93 [0.9-0.97],0.00122055032814998,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.82 [0.73-0.93],0.00129864728210145,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.16 [1.06-1.28],0.00131097228817412,cis
Chapter IX Diseases of the circulatory system,I9_IHD,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.03 [1.01-1.05],0.00154590394782296,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FGA,Fibrinogen alpha chain,Inverse variance weighted,7,0.87 [0.8-0.95],0.00158215585365069,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.93 [0.89-0.97],0.0018603331007582,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NRP1,Neuropilin-1,Inverse variance weighted,12,0.94 [0.91-0.98],0.00250153873747895,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.1 [1.03-1.17],0.00255604965657272,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,0.91 [0.86-0.97],0.00272574443469424,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CHL1,Neural cell adhesion molecule L1-like protein,Inverse variance weighted,16,1.04 [1.01-1.07],0.00297731378004779,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,1.11 [1.04-1.19],0.0031646904841565,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,1.02 [1.01-1.04],0.00353473741351752,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.04 [1.01-1.06],0.00463224774778438,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD83,CD83 antigen,Inverse variance weighted,5,1.11 [1.03-1.19],0.0051221493521653,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,0.88 [0.8-0.96],0.00557556463998344,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,0.94 [0.89-0.98],0.0066347829317884,cis
Chapter IX Diseases of the circulatory system,I9_IHD,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.07 [1.02-1.13],0.00805830749993373,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IDUA,Alpha-L-iduronidase,Inverse variance weighted,35,0.97 [0.95-0.99],0.00808671901527197,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NFASC,Neurofascin,Inverse variance weighted,15,0.96 [0.92-0.99],0.00839310095138639,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.09 [1.02-1.17],0.00840319667069991,cis
Chapter IX Diseases of the circulatory system,I9_IHD,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.9 [0.84-0.98],0.00887056094771773,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,21,0.96 [0.93-0.99],0.00901484559770031,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ANXA2,Annexin A2,Inverse variance weighted,20,1.04 [1.01-1.06],0.0103504438880308,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.98 [0.96-0.99],0.0104625561308698,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.9 [0.82-0.98],0.011139494157923,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.08 [1.02-1.16],0.0125725262874118,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.51 [1.09-2.09],0.012591564646929,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.9 [0.83-0.98],0.0129861323475305,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,0.93 [0.88-0.99],0.0143945683715903,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FUOM,Fucose mutarotase,Inverse variance weighted,3,1.17 [1.03-1.33],0.0155326052415201,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,0.91 [0.84-0.98],0.0158547884399941,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.91 [0.83-0.98],0.0170793798260652,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.04 [1.01-1.07],0.0180309425286358,cis
Chapter IX Diseases of the circulatory system,I9_IHD,KLK14,Kallikrein-14,Inverse variance weighted,15,1.04 [1.01-1.07],0.0180922988584397,cis
Chapter IX Diseases of the circulatory system,I9_IHD,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.13 [1.02-1.26],0.0190081548216039,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CLEC3B,Tetranectin,Inverse variance weighted,7,0.93 [0.88-0.99],0.0198024776693501,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PALM2,Paralemmin-2,Inverse variance weighted,8,1.07 [1.01-1.13],0.0199022535473348,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.57 [1.07-2.3],0.0206566092983359,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,1.06 [1.01-1.11],0.0211348268759014,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.04 [1.01-1.07],0.0221728802583485,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PI3,Elafin,Inverse variance weighted,10,1.05 [1.01-1.1],0.0231391205195587,cis
Chapter IX Diseases of the circulatory system,I9_IHD,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.04 [1.01-1.08],0.0245531640526291,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.09 [1.01-1.18],0.0257204838971172,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.08 [1.01-1.16],0.0260296768444556,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LDLR,Low-density lipoprotein receptor,Wald ratio,1,1.92 [1.07-3.44],0.0294917758691667,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.06 [1.01-1.11],0.0295724348957245,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CTSS,Cathepsin S,Inverse variance weighted,23,1.03 [1-1.06],0.0328251939222225,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.86 [0.75-0.99],0.033849466229049,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PLAT,Tissue-type plasminogen activator,Wald ratio,1,0.75 [0.57-0.98],0.0341151821116854,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,16,0.96 [0.93-1],0.0342370766009719,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PROK1,Prokineticin-1,Inverse variance weighted,25,0.95 [0.91-1],0.0356307998856326,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CTSL,Cathepsin L1,Wald ratio,1,0.73 [0.54-0.99],0.0397852207510084,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,1.08 [1-1.17],0.0409903253135317,cis
Chapter IX Diseases of the circulatory system,I9_IHD,KLK11,Kallikrein-11,Inverse variance weighted,6,1.03 [1-1.07],0.0421187984232055,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.95 [0.91-1],0.0441327456058772,cis
Chapter IX Diseases of the circulatory system,I9_IHD,UMOD,Uromodulin,Inverse variance weighted,29,1.02 [1-1.04],0.0442327106372048,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,32,1.03 [1-1.05],0.0449244892887124,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,1.03 [1-1.05],0.0451924367114346,cis
Chapter IX Diseases of the circulatory system,I9_IHD,F7,Coagulation factor VII,Inverse variance weighted,21,1.03 [1-1.07],0.0452575120360865,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,0.97 [0.95-1],0.047355474811632,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LIPF,Gastric triacylglycerol lipase,Inverse variance weighted,18,1.05 [1-1.11],0.0477315960760502,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.78 [0.61-1],0.0478362022380338,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TCOF1,Treacle protein,Wald ratio,1,0.76 [0.58-1],0.0490046033156768,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ELN,Elastin,Inverse variance weighted,2,1.2 [1-1.45],0.0491947171286925,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SERPINA1,Alpha-1-antitrypsin,Inverse variance weighted,4,1.08 [1-1.17],0.0497816660871096,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.91 [0.83-1],0.0504155422213524,cis
Chapter IX Diseases of the circulatory system,I9_IHD,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.96 [0.93-1],0.0515961609200048,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.97 [0.95-1],0.052855666975999,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.89 [0.8-1],0.0535670397326464,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MEGF10,Multiple epidermal growth factor-like domains protein 10,Inverse variance weighted,24,0.97 [0.93-1],0.0536164453200186,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CPE,Carboxypeptidase E,Inverse variance weighted,11,0.96 [0.92-1],0.0543462523994869,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MVK,Mevalonate kinase,Inverse variance weighted,2,0.86 [0.74-1],0.0561816522893374,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LAYN,Layilin,Inverse variance weighted,20,0.96 [0.92-1],0.0562190356888791,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.95 [0.91-1],0.0575455957771555,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.95 [0.91-1],0.059855819588459,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,0.99 [0.97-1],0.0607940368931681,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.02 [1-1.05],0.0622656314144451,cis
Chapter IX Diseases of the circulatory system,I9_IHD,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.88 [0.78-1.01],0.0627227889262783,cis
Chapter IX Diseases of the circulatory system,I9_IHD,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.22 [0.99-1.5],0.0642270892675613,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NRP2,Neuropilin-2,Inverse variance weighted,11,1.05 [1-1.11],0.0674111528070565,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LPL,Lipoprotein lipase,Inverse variance weighted,14,0.93 [0.86-1.01],0.0677621306807414,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.96 [0.92-1],0.0682331249583539,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.09 [0.99-1.2],0.0694301795973676,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.93 [0.85-1.01],0.0696943228138399,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GUCA2A,Guanylin,Inverse variance weighted,9,1.06 [1-1.13],0.0703163002936139,cis
Chapter IX Diseases of the circulatory system,I9_IHD,REN,Renin,Inverse variance weighted,4,1.07 [0.99-1.16],0.0710638765385868,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SPP1,Osteopontin,Inverse variance weighted,8,1.09 [0.99-1.2],0.0711281687171196,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,0.97 [0.93-1],0.0711328306378731,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EPO,Erythropoietin,Inverse variance weighted,5,0.86 [0.73-1.01],0.0734855196785026,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.03 [1-1.07],0.0736604128958589,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.12 [0.99-1.27],0.0745308936073506,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.79 [0.61-1.03],0.0784720282131671,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.98 [0.96-1],0.0789015633739545,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.06 [0.99-1.14],0.0828556208076452,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.11 [0.99-1.26],0.0832159172660337,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.75 [0.54-1.04],0.0833045055272832,cis
Chapter IX Diseases of the circulatory system,I9_IHD,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.04 [1-1.08],0.0837168566100594,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,0.92 [0.84-1.01],0.0855458763079577,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,0.98 [0.96-1],0.0861521933989765,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,31,1.02 [1-1.03],0.0888568386998408,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,13,1.03 [1-1.07],0.090286257131407,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.83 [0.67-1.03],0.0910522936834127,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.06 [0.99-1.14],0.0912568051478274,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.87 [0.74-1.02],0.0915231487892239,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MMP7,Matrilysin,Inverse variance weighted,13,1.03 [0.99-1.07],0.0976062188550033,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,1.06 [0.99-1.13],0.0996515603602061,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RETN,Resistin,Inverse variance weighted,9,1.02 [1-1.05],0.101598531166576,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.06 [0.99-1.14],0.102004020608784,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SCG2,Secretogranin-2,Wald ratio,1,1.28 [0.95-1.72],0.104735939220091,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD302,CD302 antigen,Inverse variance weighted,9,0.94 [0.88-1.01],0.10490280924908,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD209,CD209 antigen,Inverse variance weighted,15,0.97 [0.93-1.01],0.105511704143432,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FCRLB,Fc receptor-like B,Inverse variance weighted,61,0.99 [0.97-1],0.108889620489762,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.97 [0.94-1.01],0.109289987450732,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.91 [0.81-1.02],0.114569812425177,cis
Chapter IX Diseases of the circulatory system,I9_IHD,APOA2,Apolipoprotein A-II,Wald ratio,1,0.84 [0.68-1.04],0.115027886162798,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ACAN,Aggrecan core protein,Inverse variance weighted,3,0.9 [0.79-1.03],0.117721947770441,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,21,1.02 [0.99-1.05],0.120160720799069,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,4,0.93 [0.84-1.02],0.120450672026451,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NECTIN4,Nectin-4,Inverse variance weighted,7,1.03 [0.99-1.08],0.121906271232376,cis
Chapter IX Diseases of the circulatory system,I9_IHD,OGN,Mimecan,Inverse variance weighted,30,0.98 [0.95-1.01],0.12218063908171,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Wald ratio,1,0.86 [0.7-1.04],0.122815607209499,cis
Chapter IX Diseases of the circulatory system,I9_IHD,S100P,Protein S100-P,Inverse variance weighted,2,0.84 [0.67-1.05],0.12294702619122,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.93 [0.85-1.02],0.126887966170103,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,12,1.04 [0.99-1.09],0.127275699173691,cis
Chapter IX Diseases of the circulatory system,I9_IHD,C8B,Complement component C8 beta chain,Inverse variance weighted,21,0.98 [0.95-1.01],0.129352612329059,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.02 [0.99-1.05],0.131681052278742,cis
Chapter IX Diseases of the circulatory system,I9_IHD,INHBC,Inhibin beta C chain,Inverse variance weighted,29,1.02 [0.99-1.05],0.133043655680856,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.03 [0.99-1.06],0.137570770098328,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1.07 [0.98-1.16],0.137834859737617,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.05 [0.99-1.11],0.138216633901979,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,Inverse variance weighted,34,0.99 [0.97-1],0.139726363471588,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.05 [0.98-1.11],0.143462229628993,cis
Chapter IX Diseases of the circulatory system,I9_IHD,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,0.93 [0.85-1.02],0.143939605459465,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,0.98 [0.96-1.01],0.145971297653643,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MMP8,Neutrophil collagenase,Inverse variance weighted,17,1.02 [0.99-1.06],0.146515603775655,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PALM,Paralemmin-1,Inverse variance weighted,6,1.06 [0.98-1.14],0.151671996820926,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MXRA8,Matrix remodeling-associated protein 8,Wald ratio,1,1.15 [0.95-1.39],0.15625152593099,cis
Chapter IX Diseases of the circulatory system,I9_IHD,STC2,Stanniocalcin-2,Inverse variance weighted,3,0.9 [0.77-1.04],0.157229306445154,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD58,Lymphocyte function-associated antigen 3,Inverse variance weighted,4,0.94 [0.87-1.02],0.157372230515867,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.93 [0.84-1.03],0.157981346691545,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD160,CD160 antigen,Inverse variance weighted,11,0.97 [0.93-1.01],0.158103895189046,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,0.95 [0.9-1.02],0.161834430748947,cis
Chapter IX Diseases of the circulatory system,I9_IHD,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,9,0.95 [0.89-1.02],0.161931077283716,cis
Chapter IX Diseases of the circulatory system,I9_IHD,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,1.07 [0.97-1.18],0.16300364365527,cis
Chapter IX Diseases of the circulatory system,I9_IHD,BPIFB2,BPI fold-containing family B member 2,Inverse variance weighted,17,0.97 [0.93-1.01],0.163924426222968,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ACE,Angiotensin-converting enzyme,Inverse variance weighted,26,1.02 [0.99-1.05],0.164029107362757,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.02 [0.99-1.05],0.16416675166812,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.03 [0.99-1.08],0.164220152251302,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.02 [0.99-1.04],0.164288465456725,cis
Chapter IX Diseases of the circulatory system,I9_IHD,VEGFC,Vascular endothelial growth factor C,Inverse variance weighted,2,1.07 [0.97-1.17],0.165460305863468,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SPARC,SPARC,Inverse variance weighted,3,0.84 [0.66-1.07],0.167514006406427,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PLTP,Phospholipid transfer protein,Inverse variance weighted,19,1.02 [0.99-1.05],0.167789579468492,cis
Chapter IX Diseases of the circulatory system,I9_IHD,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.81 [0.6-1.09],0.168383561375626,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,0.95 [0.89-1.02],0.169620868147313,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.89 [0.75-1.05],0.171677955165006,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,8,0.93 [0.85-1.03],0.171964497562855,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.78 [0.55-1.11],0.174531216055116,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,1.03 [0.99-1.08],0.17470938079038,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,1.08 [0.97-1.2],0.174984087176598,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1.03 [0.99-1.07],0.175493978850511,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,26,0.98 [0.95-1.01],0.176239066815841,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ANXA10,Annexin A10,Wald ratio,1,0.83 [0.63-1.09],0.180503286601279,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,0.97 [0.92-1.02],0.180603270519208,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,4,1.07 [0.97-1.19],0.181756209567656,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,1.02 [0.99-1.06],0.183098228992198,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,12,1.02 [0.99-1.05],0.183613191825538,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MFGE8,Lactadherin,Inverse variance weighted,11,1.04 [0.98-1.09],0.18717879853837,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.97 [0.93-1.02],0.188253265382082,cis
Chapter IX Diseases of the circulatory system,I9_IHD,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,1.02 [0.99-1.04],0.191927511513313,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,0.99 [0.97-1.01],0.1924283823181,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.86 [0.69-1.08],0.195363909397897,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.02 [0.99-1.05],0.195940567186932,cis
Chapter IX Diseases of the circulatory system,I9_IHD,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,0.9 [0.77-1.05],0.197344429263171,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD46,Membrane cofactor protein,Wald ratio,1,0.9 [0.77-1.06],0.201706983887918,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CALB2,Calretinin,Wald ratio,1,0.86 [0.69-1.08],0.202188700762408,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.01 [0.99-1.04],0.20687259894099,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.1 [0.95-1.27],0.208848603791144,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.03 [0.98-1.08],0.209050214119063,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL19,Interleukin-19,Inverse variance weighted,11,1.03 [0.99-1.07],0.210359711865946,cis
Chapter IX Diseases of the circulatory system,I9_IHD,DSC2,Desmocollin-2,Inverse variance weighted,9,0.97 [0.93-1.02],0.213324768935139,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SLAMF8,SLAM family member 8,Inverse variance weighted,25,0.99 [0.98-1.01],0.213955984893862,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,1.04 [0.98-1.11],0.215939108932491,cis
Chapter IX Diseases of the circulatory system,I9_IHD,P4HB,Protein disulfide-isomerase,Inverse variance weighted,2,1.15 [0.92-1.42],0.220246541430271,cis
Chapter IX Diseases of the circulatory system,I9_IHD,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.03 [0.99-1.07],0.220984462089411,cis
Chapter IX Diseases of the circulatory system,I9_IHD,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.99 [0.97-1.01],0.221653521404559,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.05 [0.97-1.13],0.222185306396367,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.02 [0.99-1.06],0.222999003552043,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCN1,CCN family member 1,Inverse variance weighted,2,0.92 [0.82-1.05],0.223546913066226,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ADIPOQ,Adiponectin,Inverse variance weighted,13,0.97 [0.93-1.02],0.225963293630908,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MMP10,Stromelysin-2,Inverse variance weighted,22,1.02 [0.99-1.06],0.226528240064971,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GNPDA2,Glucosamine-6-phosphate isomerase 2,Inverse variance weighted,13,1.03 [0.98-1.07],0.226996036817755,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.01 [0.99-1.04],0.227478438846982,cis
Chapter IX Diseases of the circulatory system,I9_IHD,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.94 [0.85-1.04],0.227615286490924,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CDH2,Cadherin-2,Inverse variance weighted,3,1.09 [0.95-1.26],0.227743859306054,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.98 [0.94-1.02],0.228356366347331,cis
Chapter IX Diseases of the circulatory system,I9_IHD,DCTPP1,dCTP pyrophosphatase 1,Wald ratio,1,1.22 [0.88-1.67],0.229610796347655,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FABP6,Gastrotropin,Wald ratio,1,0.94 [0.84-1.04],0.232978435262843,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.03 [0.98-1.08],0.234903090678708,cis
Chapter IX Diseases of the circulatory system,I9_IHD,AKT3,RAC-gamma serine/threonine-protein kinase,Wald ratio,1,0.86 [0.67-1.11],0.235772364523236,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CFI,Complement factor I,Inverse variance weighted,6,0.94 [0.85-1.04],0.236243730041354,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.92 [0.8-1.06],0.236501024958936,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GSTA1,Glutathione S-transferase A1,Inverse variance weighted,7,0.93 [0.82-1.05],0.237277192988685,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,1.02 [0.99-1.05],0.237387016045572,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.01 [0.99-1.04],0.240011911070653,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CALCA,Calcitonin,Inverse variance weighted,5,0.94 [0.84-1.04],0.241176733820281,cis
Chapter IX Diseases of the circulatory system,I9_IHD,S100A4,Protein S100-A4,Inverse variance weighted,4,1.05 [0.97-1.14],0.241344026080806,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.98 [0.94-1.02],0.242965159217309,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.02 [0.99-1.04],0.2463237516648,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MILR1,Allergin-1,Inverse variance weighted,33,0.99 [0.97-1.01],0.247018592992166,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ITGAM,Integrin alpha-M,Inverse variance weighted,3,0.94 [0.84-1.05],0.249913399384846,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.02 [0.98-1.06],0.250389819182422,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.01 [0.99-1.03],0.254871979765134,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TMSB10,Thymosin beta-10,Wald ratio,1,1.15 [0.9-1.46],0.255148463435344,cis
Chapter IX Diseases of the circulatory system,I9_IHD,POMC,Pro-opiomelanocortin,Inverse variance weighted,2,0.81 [0.57-1.16],0.257672059164928,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Inverse variance weighted,3,0.92 [0.8-1.06],0.261154941428981,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ERBB3,Receptor tyrosine-protein kinase erbB-3,Inverse variance weighted,7,0.97 [0.91-1.03],0.261481480079514,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.02 [0.99-1.05],0.264028666630905,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.98 [0.95-1.01],0.26507773758826,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.94 [0.85-1.05],0.265730299518191,cis
Chapter IX Diseases of the circulatory system,I9_IHD,BPIFA2,BPI fold-containing family A member 2,Inverse variance weighted,5,1.04 [0.97-1.12],0.265735857212581,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.07 [0.95-1.21],0.265886275673905,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MPO,Myeloperoxidase,Inverse variance weighted,11,1.02 [0.98-1.06],0.267259397310508,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.26 [0.84-1.9],0.268358517472485,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.94 [0.85-1.05],0.269031315477423,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,27,0.98 [0.96-1.01],0.271054842478736,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,0.96 [0.89-1.03],0.271363471441638,cis
Chapter IX Diseases of the circulatory system,I9_IHD,F11R,Junctional adhesion molecule A,Wald ratio,1,1.14 [0.9-1.43],0.272310683857658,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.98 [0.96-1.01],0.272344196344158,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNN,Tenascin-N,Inverse variance weighted,44,1.01 [0.99-1.03],0.273909862726355,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,0.8 [0.53-1.2],0.280077934526231,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.01 [0.99-1.03],0.281897289560406,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SERPINB8,Serpin B8,Inverse variance weighted,28,1.01 [0.99-1.03],0.284635716637552,cis
Chapter IX Diseases of the circulatory system,I9_IHD,COLEC12,Collectin-12,Inverse variance weighted,11,1.03 [0.98-1.09],0.287619923378484,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MET,Hepatocyte growth factor receptor,Inverse variance weighted,5,1.13 [0.9-1.44],0.292526281025612,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,43,1.01 [0.99-1.04],0.29271488221225,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,0.96 [0.9-1.03],0.294589954901968,cis
Chapter IX Diseases of the circulatory system,I9_IHD,KLK4,Kallikrein-4,Inverse variance weighted,17,1.02 [0.99-1.05],0.295152789064853,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TMPRSS15,Enteropeptidase,Inverse variance weighted,3,0.93 [0.81-1.06],0.295588723388394,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.02 [0.99-1.05],0.295660696413243,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SEPTIN8,Septin-8,Inverse variance weighted,2,1.05 [0.95-1.16],0.300185891353121,cis
Chapter IX Diseases of the circulatory system,I9_IHD,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,0.97 [0.92-1.03],0.300814093535151,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NT5C3A,Cytosolic 5'-nucleotidase 3A,Wald ratio,1,0.93 [0.81-1.07],0.302694090257914,cis
Chapter IX Diseases of the circulatory system,I9_IHD,VWC2,Brorin,Inverse variance weighted,22,0.98 [0.95-1.02],0.302868699153383,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SDC1,Syndecan-1,Inverse variance weighted,2,1.05 [0.95-1.17],0.305460215677418,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CDH1,Cadherin-1,Wald ratio,1,0.86 [0.63-1.16],0.311179115261376,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,1.03 [0.97-1.08],0.312720506030632,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SERPIND1,Heparin cofactor 2,Wald ratio,1,1.09 [0.92-1.28],0.313907639020319,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.98 [0.95-1.02],0.314561909804848,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.97 [0.92-1.03],0.315988430643695,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MASP1,Mannan-binding lectin serine protease 1,Inverse variance weighted,9,0.97 [0.91-1.03],0.318413876420095,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CAPG,Macrophage-capping protein,Inverse variance weighted,33,0.98 [0.95-1.02],0.319407367345401,cis
Chapter IX Diseases of the circulatory system,I9_IHD,BDNF,Brain-derived neurotrophic factor,Wald ratio,1,0.91 [0.75-1.1],0.322563296522845,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.02 [0.98-1.07],0.32495386598428,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MB,Myoglobin,Wald ratio,1,1.2 [0.83-1.75],0.326817892803826,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PLA2G1B,Phospholipase A2,Wald ratio,1,0.89 [0.7-1.13],0.327732885750133,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,11,1.02 [0.98-1.07],0.329804865993875,cis
Chapter IX Diseases of the circulatory system,I9_IHD,KLKB1,Plasma kallikrein,Inverse variance weighted,15,1.02 [0.98-1.05],0.330057377924094,cis
Chapter IX Diseases of the circulatory system,I9_IHD,APOA1,Apolipoprotein A-I,Inverse variance weighted,2,1.32 [0.75-2.32],0.336939278952629,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PENK,Proenkephalin-A,Inverse variance weighted,19,1.02 [0.98-1.06],0.337071779565514,cis
Chapter IX Diseases of the circulatory system,I9_IHD,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.03 [0.97-1.09],0.340296083633405,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.01 [0.98-1.05],0.34234307681481,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,11,1.02 [0.98-1.07],0.346952607096526,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FGFBP3,Fibroblast growth factor-binding protein 3,Inverse variance weighted,19,0.98 [0.93-1.03],0.349554994900313,cis
Chapter IX Diseases of the circulatory system,I9_IHD,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.04 [0.96-1.12],0.35116630720255,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.02 [0.98-1.06],0.352033133579423,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,9,1.06 [0.94-1.19],0.35318417523471,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.06 [0.94-1.18],0.354241881226102,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MMP3,Stromelysin-1,Inverse variance weighted,34,0.98 [0.94-1.02],0.356438707703038,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,0.98 [0.93-1.03],0.360757284716742,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.95 [0.86-1.06],0.361481003509797,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CFHR4,Complement factor H-related protein 4,Inverse variance weighted,55,0.99 [0.98-1.01],0.362092795873448,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.95 [0.86-1.06],0.362209509160614,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,0.96 [0.88-1.05],0.362975395440652,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,Inverse variance weighted,2,1.04 [0.95-1.14],0.364910779974744,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FAM3D,Protein FAM3D,Inverse variance weighted,17,1.03 [0.97-1.09],0.365791570660548,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LGALS1,Galectin-1,Inverse variance weighted,6,1.02 [0.98-1.06],0.366474738155344,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,34,1.01 [0.99-1.03],0.366632611240825,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,0.97 [0.91-1.04],0.366787660243669,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.97 [0.91-1.03],0.369601281678702,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CTSB,Cathepsin B,Inverse variance weighted,26,1.01 [0.99-1.04],0.374231666329512,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.98 [0.94-1.02],0.374614876251314,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GAL,Galanin peptides,Inverse variance weighted,3,0.9 [0.7-1.14],0.375695184602974,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.01 [0.99-1.04],0.375729805984334,cis
Chapter IX Diseases of the circulatory system,I9_IHD,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.91 [0.73-1.13],0.378551664430336,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,Inverse variance weighted,12,1.02 [0.97-1.07],0.37871932069716,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PTN,Pleiotrophin,Inverse variance weighted,4,1.06 [0.94-1.19],0.380244049701278,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,0.96 [0.86-1.06],0.381962393660028,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.98 [0.93-1.03],0.382482477989867,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,0.91 [0.73-1.13],0.383814467893904,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL5,C-X-C motif chemokine 5,Inverse variance weighted,11,1.02 [0.98-1.05],0.384355998585935,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CALB1,Calbindin,Inverse variance weighted,2,0.93 [0.79-1.1],0.385655154826091,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ITGA6,Integrin alpha-6,Inverse variance weighted,10,1.03 [0.97-1.09],0.38884045987652,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CFH,Complement factor H,Inverse variance weighted,19,0.98 [0.93-1.03],0.390842329277076,cis
Chapter IX Diseases of the circulatory system,I9_IHD,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.02 [0.98-1.06],0.39525621639686,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FOLR2,Folate receptor beta,Inverse variance weighted,2,0.95 [0.85-1.07],0.395358110531376,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SPON1,Spondin-1,Inverse variance weighted,21,1.02 [0.98-1.05],0.397528441284017,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SPON2,Spondin-2,Inverse variance weighted,4,1.03 [0.96-1.12],0.398165114342639,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.99 [0.97-1.01],0.399238448411333,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.04 [0.95-1.15],0.401555398569316,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PRSS8,Prostasin,Inverse variance weighted,5,0.93 [0.78-1.1],0.403040578429683,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PDGFA,Platelet-derived growth factor subunit A,Inverse variance weighted,2,1.08 [0.9-1.3],0.404789330071222,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RSPO1,R-spondin-1,Inverse variance weighted,5,1.02 [0.97-1.09],0.404985886855426,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.07 [0.91-1.27],0.410485766828794,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.02 [0.98-1.06],0.411024533629577,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.9 [0.69-1.16],0.412554580237302,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,21,1.02 [0.98-1.06],0.413469911880854,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCN4,CCN family member 4,Inverse variance weighted,27,1.01 [0.98-1.04],0.413796687515976,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HMOX1,Heme oxygenase 1,Wald ratio,1,1.09 [0.88-1.35],0.414428833967461,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,0.99 [0.97-1.01],0.414697291888081,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,0.98 [0.95-1.02],0.41490810941603,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.02 [0.97-1.06],0.416555029724555,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.07 [0.9-1.27],0.417918359699886,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,15,1.02 [0.98-1.05],0.418721234310924,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,1.1 [0.87-1.38],0.419253702628354,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FBLN2,Fibulin-2,Inverse variance weighted,11,1.02 [0.98-1.05],0.422812043284358,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ITGA2,Integrin alpha-2,Inverse variance weighted,31,0.99 [0.96-1.02],0.425340880372751,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Wald ratio,1,0.94 [0.79-1.1],0.428588044004904,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MARCO,Macrophage receptor MARCO,Inverse variance weighted,10,0.98 [0.92-1.04],0.430560220596107,cis
Chapter IX Diseases of the circulatory system,I9_IHD,APCS,Serum amyloid P-component,Inverse variance weighted,4,0.97 [0.89-1.05],0.43097507601809,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,0.99 [0.97-1.01],0.431720026792116,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.98 [0.94-1.03],0.432861017219902,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HEPACAM2,HEPACAM family member 2,Wald ratio,1,1.33 [0.65-2.75],0.435262780629993,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CST3,Cystatin-C,Inverse variance weighted,10,1.02 [0.97-1.08],0.435629303893965,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,0.98 [0.92-1.03],0.437082704034012,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GUSB,Beta-glucuronidase,Inverse variance weighted,4,1.04 [0.94-1.14],0.437944866567364,cis
Chapter IX Diseases of the circulatory system,I9_IHD,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,0.98 [0.94-1.03],0.438354682675285,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCN3,CCN family member 3,Inverse variance weighted,19,0.98 [0.93-1.03],0.438736957171852,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1.04 [0.94-1.15],0.441237259763512,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.15 [0.81-1.63],0.441242865123218,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SDC4,Syndecan-4,Inverse variance weighted,8,1.04 [0.94-1.16],0.446505595268907,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,39,0.99 [0.96-1.02],0.448561940940316,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.01 [0.98-1.05],0.448647616856535,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,1.05 [0.92-1.19],0.449242953475039,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.02 [0.97-1.08],0.454120205121548,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,10,1.02 [0.97-1.07],0.456013801851961,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL17C,Interleukin-17C,Inverse variance weighted,3,0.96 [0.87-1.07],0.457209108075858,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.95 [0.81-1.1],0.458025873045591,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PRSS2,Trypsin-2,Inverse variance weighted,3,0.97 [0.88-1.06],0.461757663826501,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LPO,Lactoperoxidase,Inverse variance weighted,4,1.02 [0.97-1.06],0.467528018343879,cis
Chapter IX Diseases of the circulatory system,I9_IHD,KIF1C,Kinesin-like protein KIF1C,Wald ratio,1,1.17 [0.77-1.77],0.467734844191377,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.99 [0.95-1.02],0.469226990016858,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL8,C-C motif chemokine 8,Inverse variance weighted,30,0.99 [0.97-1.01],0.469507829937584,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,0.97 [0.88-1.06],0.470469826187026,cis
Chapter IX Diseases of the circulatory system,I9_IHD,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.95 [0.84-1.09],0.470659306762052,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,0.98 [0.93-1.03],0.477794976172347,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,1.03 [0.95-1.12],0.480836227275358,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PGA4,Pepsin A-4,Inverse variance weighted,2,1.13 [0.81-1.58],0.481720717476603,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SCG3,Secretogranin-3,Inverse variance weighted,32,1.01 [0.98-1.04],0.481765131290551,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CTSD,Cathepsin D,Inverse variance weighted,17,1.01 [0.98-1.05],0.483134640897698,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,12,1.02 [0.96-1.08],0.484404207329457,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,1.01 [0.97-1.06],0.48466880237386,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,7,1.03 [0.96-1.1],0.484713610810988,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.01 [0.98-1.04],0.485207622812842,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,0.99 [0.95-1.03],0.485450294179207,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.99 [0.97-1.01],0.486140288874023,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GPC5,Glypican-5,Inverse variance weighted,33,0.99 [0.97-1.02],0.48900937406005,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.05 [0.92-1.19],0.490760601872261,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,1.01 [0.98-1.04],0.492516298030421,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MSLN,Mesothelin,Inverse variance weighted,25,1.01 [0.98-1.03],0.494399789052992,cis
Chapter IX Diseases of the circulatory system,I9_IHD,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.9 [0.67-1.22],0.495547510646534,cis
Chapter IX Diseases of the circulatory system,I9_IHD,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1.02 [0.96-1.09],0.498888972992703,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.96 [0.87-1.07],0.500801639049938,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.9 [0.67-1.22],0.502588569577789,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.01 [0.98-1.05],0.503359264941643,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.03 [0.94-1.14],0.507531638962463,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GSN,Gelsolin,Inverse variance weighted,5,1.06 [0.9-1.25],0.507604793288956,cis
Chapter IX Diseases of the circulatory system,I9_IHD,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,0.98 [0.94-1.03],0.508059407480009,cis
Chapter IX Diseases of the circulatory system,I9_IHD,C7,Complement component C7,Inverse variance weighted,38,1.01 [0.99-1.03],0.50943031011252,cis
Chapter IX Diseases of the circulatory system,I9_IHD,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.01 [0.98-1.04],0.509489600910444,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.09 [0.84-1.42],0.509518929565012,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1.03 [0.95-1.1],0.513040757600276,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,0.99 [0.97-1.01],0.513543945827427,cis
Chapter IX Diseases of the circulatory system,I9_IHD,AMBP,Protein AMBP,Inverse variance weighted,3,0.96 [0.85-1.09],0.515527936691983,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,0.99 [0.95-1.03],0.518325463531563,cis
Chapter IX Diseases of the circulatory system,I9_IHD,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.98 [0.92-1.04],0.518773863404297,cis
Chapter IX Diseases of the circulatory system,I9_IHD,THPO,Thrombopoietin,Inverse variance weighted,3,1.06 [0.89-1.25],0.520709601128584,cis
Chapter IX Diseases of the circulatory system,I9_IHD,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.97 [0.89-1.06],0.522523887615137,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SERPINE1,Plasminogen activator inhibitor 1,Inverse variance weighted,4,0.93 [0.74-1.17],0.522596971688885,cis
Chapter IX Diseases of the circulatory system,I9_IHD,AGRP,Agouti-related protein,Inverse variance weighted,3,0.91 [0.68-1.22],0.527301230585025,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.02 [0.96-1.09],0.529104501964457,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NTF3,Neurotrophin-3,Inverse variance weighted,8,1.04 [0.93-1.16],0.532423800396578,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RTBDN,Retbindin,Inverse variance weighted,3,0.97 [0.89-1.06],0.535346062321672,cis
Chapter IX Diseases of the circulatory system,I9_IHD,APOF,Apolipoprotein F,Inverse variance weighted,3,1.03 [0.94-1.12],0.535399612874319,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,1.01 [0.99-1.03],0.535581448120326,cis
Chapter IX Diseases of the circulatory system,I9_IHD,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.02 [0.95-1.09],0.540259606965694,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.01 [0.97-1.05],0.540843784564702,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,1.01 [0.98-1.05],0.542774484242767,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.08 [0.84-1.4],0.545798365317057,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GHRL,Appetite-regulating hormone,Inverse variance weighted,3,1.01 [0.98-1.04],0.550201140042553,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,0.96 [0.82-1.11],0.550294534612116,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.02 [0.96-1.09],0.551126872966179,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.04 [0.92-1.17],0.551303095644061,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,0.99 [0.95-1.03],0.551810890242394,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL19,C-C motif chemokine 19,Inverse variance weighted,2,0.96 [0.84-1.1],0.554343594735548,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1.03 [0.94-1.12],0.558236338654221,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,1.03 [0.93-1.15],0.558592279782708,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,1.02 [0.96-1.08],0.562021718004938,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.98 [0.93-1.04],0.562675376677556,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ANG,Angiogenin,Inverse variance weighted,19,1.01 [0.98-1.04],0.564964337121984,cis
Chapter IX Diseases of the circulatory system,I9_IHD,F10,Coagulation factor X,Inverse variance weighted,9,1.01 [0.98-1.03],0.565550520432424,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,0.99 [0.96-1.02],0.566709585371588,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,0.99 [0.97-1.02],0.571599016590659,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LGALS9,Galectin-9,Inverse variance weighted,26,0.99 [0.96-1.02],0.573181597661476,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NPPC,C-type natriuretic peptide,Wald ratio,1,0.91 [0.65-1.27],0.573568024910641,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.97 [0.87-1.08],0.573863036804844,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.03 [0.94-1.12],0.574263389717249,cis
Chapter IX Diseases of the circulatory system,I9_IHD,BSG,Basigin,Wald ratio,1,1.03 [0.93-1.14],0.5759422570564,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.99 [0.96-1.02],0.578657146836151,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,1.01 [0.97-1.05],0.580249936708555,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.03 [0.94-1.12],0.584530938949199,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CFD,Complement factor D,Inverse variance weighted,11,0.99 [0.94-1.03],0.587230411001092,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.01 [0.98-1.04],0.58962695046565,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.98 [0.9-1.06],0.590599127950344,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,1.02 [0.94-1.11],0.59124611813265,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,16,0.99 [0.96-1.02],0.592566196597187,cis
Chapter IX Diseases of the circulatory system,I9_IHD,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,1.04 [0.91-1.18],0.593560100846258,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MENT,Protein MENT,Inverse variance weighted,3,1.02 [0.96-1.08],0.593850215344114,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,0.97 [0.88-1.07],0.600682575389981,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL17,C-C motif chemokine 17,Inverse variance weighted,9,1.02 [0.95-1.09],0.601438886497617,cis
Chapter IX Diseases of the circulatory system,I9_IHD,VWF,von Willebrand factor,Inverse variance weighted,2,1.03 [0.92-1.17],0.601463860274269,cis
Chapter IX Diseases of the circulatory system,I9_IHD,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.01 [0.96-1.07],0.601672073229429,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CLPS,Colipase,Inverse variance weighted,39,1.01 [0.98-1.03],0.602450820879135,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL15,Interleukin-15,Wald ratio,1,1.39 [0.4-4.87],0.6035850987651,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IDO1,"Indoleamine 2,3-dioxygenase 1",Inverse variance weighted,13,0.99 [0.95-1.03],0.606370703632062,cis
Chapter IX Diseases of the circulatory system,I9_IHD,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,1.03 [0.92-1.14],0.607516016894594,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.02 [0.93-1.12],0.608134280815764,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD34,Hematopoietic progenitor cell antigen CD34,Wald ratio,1,1.06 [0.84-1.35],0.610952561072342,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,3,0.97 [0.87-1.09],0.611822980412841,cis
Chapter IX Diseases of the circulatory system,I9_IHD,APOD,Apolipoprotein D,Inverse variance weighted,7,0.99 [0.94-1.04],0.61189887447052,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ANGPT1,Angiopoietin-1,Inverse variance weighted,2,1.05 [0.86-1.29],0.617039319081773,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,1.01 [0.97-1.06],0.61755026088349,cis
Chapter IX Diseases of the circulatory system,I9_IHD,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,1.04 [0.88-1.24],0.619555238225065,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.02 [0.95-1.1],0.623255090578506,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CTSO,Cathepsin O,Inverse variance weighted,6,0.98 [0.92-1.05],0.624758484482695,cis
Chapter IX Diseases of the circulatory system,I9_IHD,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.06 [0.83-1.37],0.626053973187869,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,0.98 [0.89-1.07],0.627594438797273,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SERPINA6,Corticosteroid-binding globulin,Inverse variance weighted,9,1.02 [0.95-1.09],0.630142464490306,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,1.01 [0.96-1.06],0.634425304945856,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.94 [0.73-1.21],0.638263241787032,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.99 [0.94-1.04],0.640458113063527,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.06 [0.82-1.38],0.641630789145665,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.97 [0.85-1.1],0.643066053089646,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.99 [0.96-1.03],0.644148781822543,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,1.02 [0.93-1.12],0.644453293707022,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,1.03 [0.91-1.16],0.645972941542034,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,1.01 [0.97-1.05],0.647853811851335,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.01 [0.96-1.07],0.648004066302249,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,2,1.04 [0.89-1.22],0.649358273538228,cis
Chapter IX Diseases of the circulatory system,I9_IHD,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.09 [0.75-1.6],0.652195126152891,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.98 [0.89-1.08],0.652905929120597,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.98 [0.92-1.05],0.654043077406567,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.01 [0.97-1.05],0.657923637146507,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.97 [0.83-1.13],0.65819660372997,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,10,1.01 [0.97-1.06],0.658723657888669,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,25,1 [0.99-1.02],0.659163330411934,cis
Chapter IX Diseases of the circulatory system,I9_IHD,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.93 [0.67-1.29],0.662083052737259,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.11 [0.7-1.75],0.666151169196561,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1 [0.98-1.01],0.667349407998358,cis
Chapter IX Diseases of the circulatory system,I9_IHD,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1.03 [0.89-1.2],0.668566381078162,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GRN,Progranulin,Inverse variance weighted,7,1.01 [0.96-1.06],0.672490929589143,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.99 [0.94-1.04],0.672582579498319,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.94 [0.72-1.23],0.674136965615783,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.93 [0.67-1.29],0.67490113284869,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.02 [0.93-1.12],0.676169715084291,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,1 [0.99-1.02],0.677334766676733,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PKD1,Polycystin-1,Inverse variance weighted,12,0.99 [0.94-1.04],0.679606972392578,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1 [0.98-1.02],0.684711431993117,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.97 [0.83-1.13],0.685674901761771,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.99 [0.96-1.03],0.687148109846863,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,1.02 [0.92-1.13],0.687472442399315,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,0.99 [0.93-1.05],0.692996089028087,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.97 [0.83-1.13],0.698526942312308,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,1.01 [0.96-1.07],0.699549166436206,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MCAM,Cell surface glycoprotein MUC18,Wald ratio,1,0.98 [0.88-1.09],0.699956363814619,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.01 [0.97-1.04],0.700095841326414,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PRG2,Bone marrow proteoglycan,Wald ratio,1,0.97 [0.81-1.16],0.700322115153284,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EDN1,Endothelin-1,Inverse variance weighted,3,1.01 [0.95-1.08],0.702291026455088,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CLIC5,Chloride intracellular channel protein 5,Inverse variance weighted,2,0.95 [0.73-1.24],0.705582888857182,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SELL,L-selectin,Inverse variance weighted,18,0.99 [0.96-1.03],0.706923127433345,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.01 [0.96-1.06],0.70858586707346,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.96 [0.78-1.18],0.714081282003329,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.99 [0.92-1.06],0.718118967683243,cis
Chapter IX Diseases of the circulatory system,I9_IHD,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,0.94 [0.67-1.32],0.71866018241181,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCN5,CCN family member 5,Inverse variance weighted,8,0.98 [0.86-1.11],0.721764643679886,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.01 [0.94-1.09],0.724972876800426,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PSAP,Prosaposin,Inverse variance weighted,5,0.99 [0.92-1.06],0.725490596282594,cis
Chapter IX Diseases of the circulatory system,I9_IHD,F13B,Coagulation factor XIII B chain,Inverse variance weighted,33,1.01 [0.97-1.05],0.726764498825655,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.98 [0.87-1.1],0.727044429315644,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,47,1 [0.98-1.01],0.730388740753315,cis
Chapter IX Diseases of the circulatory system,I9_IHD,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,0.99 [0.93-1.06],0.734690044734118,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.98 [0.86-1.11],0.744175418620958,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.98 [0.86-1.11],0.748390897025403,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.96 [0.73-1.26],0.751533725823496,cis
Chapter IX Diseases of the circulatory system,I9_IHD,KLB,Beta-klotho,Inverse variance weighted,32,1 [0.98-1.02],0.754468186878809,cis
Chapter IX Diseases of the circulatory system,I9_IHD,OCLN,Occludin,Inverse variance weighted,2,0.98 [0.88-1.1],0.755119205717619,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.99 [0.92-1.06],0.755477306759183,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL13,C-C motif chemokine 13,Inverse variance weighted,8,0.99 [0.95-1.04],0.760722476898485,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1 [0.98-1.02],0.761799562603929,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CSTB,Cystatin-B,Inverse variance weighted,28,1 [0.98-1.03],0.763497683320221,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IFNL1,Interferon lambda-1,Wald ratio,1,1.05 [0.76-1.45],0.76372593676345,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,0.99 [0.96-1.03],0.764568676504526,cis
Chapter IX Diseases of the circulatory system,I9_IHD,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.98 [0.86-1.12],0.765861797713131,cis
Chapter IX Diseases of the circulatory system,I9_IHD,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,2,0.97 [0.8-1.18],0.771518310217431,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.01 [0.94-1.09],0.77442200044725,cis
Chapter IX Diseases of the circulatory system,I9_IHD,OSM,Oncostatin-M,Wald ratio,1,0.97 [0.79-1.19],0.779590953890869,cis
Chapter IX Diseases of the circulatory system,I9_IHD,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,16,1 [0.96-1.03],0.780005247090489,cis
Chapter IX Diseases of the circulatory system,I9_IHD,AREG,Amphiregulin,Inverse variance weighted,3,0.98 [0.85-1.13],0.782353662955793,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CHGB,Secretogranin-1,Inverse variance weighted,27,1 [0.98-1.03],0.783779463445877,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1.01 [0.97-1.04],0.784120915046602,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SIAE,Sialate O-acetylesterase,Inverse variance weighted,3,0.99 [0.93-1.06],0.786638355715604,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RSPO3,R-spondin-3,Inverse variance weighted,6,1.01 [0.94-1.09],0.787979089546608,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.99 [0.94-1.05],0.788380844484929,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MDK,Midkine,Inverse variance weighted,4,1.02 [0.9-1.14],0.789049137116233,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.01 [0.95-1.08],0.790523302266564,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RBP2,Retinol-binding protein 2,Wald ratio,1,1.03 [0.82-1.3],0.791432914611967,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PRND,Prion-like protein doppel,Inverse variance weighted,9,1 [0.96-1.03],0.793552848840991,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MME,Neprilysin,Inverse variance weighted,3,0.97 [0.78-1.21],0.794415886790176,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CNTN5,Contactin-5,Inverse variance weighted,28,1 [0.98-1.03],0.797454512526389,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.99 [0.95-1.04],0.79832393364557,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1 [0.98-1.02],0.798886553704618,cis
Chapter IX Diseases of the circulatory system,I9_IHD,BCAN,Brevican core protein,Inverse variance weighted,3,1.01 [0.95-1.07],0.800571146054684,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GPR15L,Protein GPR15L,Inverse variance weighted,9,1.01 [0.96-1.05],0.802697841238692,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.02 [0.89-1.16],0.810984855453285,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IGSF9,Protein turtle homolog A,Inverse variance weighted,10,0.99 [0.94-1.05],0.813730699896494,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.98 [0.83-1.16],0.813897452757544,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ROBO2,Roundabout homolog 2,Inverse variance weighted,2,1.03 [0.83-1.26],0.814025041173601,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LMNB2,Lamin-B2,Wald ratio,1,0.96 [0.68-1.35],0.81407188471154,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.99 [0.88-1.11],0.81671462732881,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,0.99 [0.87-1.12],0.81671462732881,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PYY,Peptide YY,Inverse variance weighted,6,1.01 [0.95-1.06],0.821362351976617,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CHGA,Chromogranin-A,Inverse variance weighted,3,0.99 [0.86-1.12],0.824697661962273,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1 [0.98-1.03],0.825140560771305,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,0.99 [0.93-1.06],0.828408809759,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,1.01 [0.89-1.15],0.832341785040258,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MUC13,Mucin-13,Inverse variance weighted,9,1.01 [0.95-1.06],0.833516047361981,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GPD1,Glycerol-3-phosphate dehydrogenase,Wald ratio,1,0.98 [0.78-1.22],0.837309119951243,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LGALS4,Galectin-4,Inverse variance weighted,4,1.01 [0.93-1.1],0.838862878143197,cis
Chapter IX Diseases of the circulatory system,I9_IHD,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1 [0.97-1.04],0.839162643660287,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,4,1.01 [0.96-1.06],0.839188573467553,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LGMN,Legumain,Inverse variance weighted,12,1 [0.97-1.04],0.841278679793543,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1 [0.97-1.04],0.843526254420153,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL17D,Interleukin-17D,Inverse variance weighted,15,1 [0.95-1.04],0.846307448425094,cis
Chapter IX Diseases of the circulatory system,I9_IHD,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.02 [0.85-1.22],0.846327307745955,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.99 [0.92-1.07],0.848259934537861,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.99 [0.94-1.05],0.849177237827692,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NECTIN2,Nectin-2,Inverse variance weighted,5,0.99 [0.89-1.1],0.850876613164966,cis
Chapter IX Diseases of the circulatory system,I9_IHD,UPB1,Beta-ureidopropionase,Inverse variance weighted,3,1.01 [0.88-1.17],0.850904890230274,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1 [0.97-1.03],0.851530991108549,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD276,CD276 antigen,Inverse variance weighted,20,1 [0.96-1.03],0.85576698559867,cis
Chapter IX Diseases of the circulatory system,I9_IHD,AGRN,Agrin,Inverse variance weighted,17,1 [0.95-1.04],0.856611637646245,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PROC,Vitamin K-dependent protein C,Inverse variance weighted,4,0.98 [0.82-1.18],0.860294183679146,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,0.99 [0.9-1.09],0.860474913157874,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.01 [0.89-1.15],0.863278525780667,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,0.99 [0.84-1.15],0.864310347287394,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.99 [0.84-1.16],0.865800701027496,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FAM3B,Protein FAM3B,Inverse variance weighted,18,1 [0.96-1.03],0.868000448472865,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,1 [0.97-1.04],0.868490129504036,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FOLR1,Folate receptor alpha,Inverse variance weighted,5,0.99 [0.91-1.09],0.869018661627929,cis
Chapter IX Diseases of the circulatory system,I9_IHD,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,0.99 [0.84-1.16],0.870755724727707,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,0.98 [0.74-1.29],0.871141955534747,cis
Chapter IX Diseases of the circulatory system,I9_IHD,VSNL1,Visinin-like protein 1,Inverse variance weighted,8,0.99 [0.88-1.11],0.874171872887791,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1 [0.94-1.05],0.87485485351763,cis
Chapter IX Diseases of the circulatory system,I9_IHD,KLK8,Kallikrein-8,Inverse variance weighted,12,1 [0.96-1.05],0.878370247948384,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GHR,Growth hormone receptor,Inverse variance weighted,38,1 [0.98-1.02],0.88047945336505,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1 [0.95-1.04],0.882128064029365,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL18,Interleukin-18,Inverse variance weighted,16,0.99 [0.91-1.09],0.883937324795875,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CD27,CD27 antigen,Inverse variance weighted,9,1 [0.94-1.05],0.888153135279353,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ITGA5,Integrin alpha-5,Wald ratio,1,1.02 [0.8-1.29],0.888801627661506,cis
Chapter IX Diseases of the circulatory system,I9_IHD,HJV,Hemojuvelin,Wald ratio,1,1.01 [0.93-1.08],0.891209676447846,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1 [0.93-1.06],0.891809287802615,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.01 [0.93-1.09],0.893316959873866,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.01 [0.88-1.15],0.894390807236168,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1 [0.95-1.04],0.900365781033769,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,1 [0.98-1.03],0.900372976695796,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,1 [0.97-1.03],0.905155308109386,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1 [0.94-1.07],0.907407726003909,cis
Chapter IX Diseases of the circulatory system,I9_IHD,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,4,1 [0.95-1.06],0.907831202666188,cis
Chapter IX Diseases of the circulatory system,I9_IHD,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,1 [0.96-1.05],0.907897236641697,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,19,1 [0.97-1.03],0.909703206522759,cis
Chapter IX Diseases of the circulatory system,I9_IHD,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1 [0.98-1.03],0.911655202791153,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1 [0.93-1.06],0.912287027172118,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CPM,Carboxypeptidase M,Inverse variance weighted,4,1 [0.92-1.09],0.913048228043035,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LGALS3,Galectin-3,Inverse variance weighted,25,1 [0.97-1.03],0.920395283906326,cis
Chapter IX Diseases of the circulatory system,I9_IHD,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1 [0.97-1.03],0.920446658139044,cis
Chapter IX Diseases of the circulatory system,I9_IHD,APOL1,Apolipoprotein L1,Inverse variance weighted,3,1 [0.93-1.08],0.921380461777906,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CREG1,Protein CREG1,Inverse variance weighted,3,1 [0.92-1.08],0.922807244391639,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1 [0.91-1.1],0.924133705051297,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1 [0.96-1.05],0.930184609361143,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FASLG,Tumor necrosis factor ligand superfamily member 6,Wald ratio,1,0.99 [0.81-1.22],0.930589134711642,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.01 [0.8-1.27],0.931116657327055,cis
Chapter IX Diseases of the circulatory system,I9_IHD,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.99 [0.79-1.24],0.931748721513133,cis
Chapter IX Diseases of the circulatory system,I9_IHD,DPT,Dermatopontin,Inverse variance weighted,21,1 [0.95-1.04],0.933446750321351,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,1 [0.94-1.07],0.933893083540058,cis
Chapter IX Diseases of the circulatory system,I9_IHD,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1 [0.95-1.06],0.935654950469391,cis
Chapter IX Diseases of the circulatory system,I9_IHD,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1 [0.94-1.06],0.939418710622097,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1 [0.98-1.02],0.940482533431639,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1 [0.93-1.07],0.941478818922659,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.99 [0.69-1.42],0.942462910083713,cis
Chapter IX Diseases of the circulatory system,I9_IHD,XCL1,Lymphotactin,Inverse variance weighted,31,1 [0.97-1.03],0.942691141191145,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.01 [0.85-1.19],0.945764997844695,cis
Chapter IX Diseases of the circulatory system,I9_IHD,DARS1,"Aspartate--tRNA ligase, cytoplasmic",Inverse variance weighted,2,1.01 [0.86-1.18],0.946586770737541,cis
Chapter IX Diseases of the circulatory system,I9_IHD,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1 [0.96-1.04],0.948198418431103,cis
Chapter IX Diseases of the circulatory system,I9_IHD,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,1 [0.9-1.11],0.950842927182997,cis
Chapter IX Diseases of the circulatory system,I9_IHD,AFP,Alpha-fetoprotein,Inverse variance weighted,5,1 [0.9-1.11],0.952450643306738,cis
Chapter IX Diseases of the circulatory system,I9_IHD,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,1 [0.98-1.02],0.954970693118078,cis
Chapter IX Diseases of the circulatory system,I9_IHD,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1 [0.98-1.02],0.966671810651021,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1 [0.97-1.03],0.9668148598836,cis
Chapter IX Diseases of the circulatory system,I9_IHD,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1 [0.96-1.04],0.9680458990872,cis
Chapter IX Diseases of the circulatory system,I9_IHD,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,1 [0.97-1.03],0.969089208986853,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,3,1.01 [0.72-1.4],0.969645053267751,cis
Chapter IX Diseases of the circulatory system,I9_IHD,EFNA4,Ephrin-A4,Inverse variance weighted,3,1 [0.85-1.18],0.973793368730744,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1 [0.88-1.14],0.974355331746566,cis
Chapter IX Diseases of the circulatory system,I9_IHD,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1 [0.91-1.11],0.976876544790499,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1 [0.95-1.05],0.98003363133721,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1 [0.94-1.07],0.980670898242697,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1 [0.96-1.04],0.981013873615724,cis
Chapter IX Diseases of the circulatory system,I9_IHD,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,1 [0.98-1.02],0.986620960295061,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,31,1 [0.97-1.03],0.98729061699327,cis
Chapter IX Diseases of the circulatory system,I9_IHD,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],Inverse variance weighted,10,1 [0.95-1.05],0.989662976779546,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1 [0.95-1.05],0.991057483065022,cis
Chapter IX Diseases of the circulatory system,I9_IHD,PGF,Placenta growth factor,Inverse variance weighted,2,1 [0.7-1.44],0.991352387965897,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1 [0.93-1.07],0.995101083059648,cis
Chapter IX Diseases of the circulatory system,I9_IHD,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1 [0.95-1.05],0.9973854841618,cis
Chapter IX Diseases of the circulatory system,I9_IHD,SPOCK1,Testican-1,Inverse variance weighted,6,1 [0.91-1.1],0.997843395791827,cis
Chapter IX Diseases of the circulatory system,I9_IHD,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1 [0.83-1.2],0.998964074104869,cis
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,8.07 [5.97-10.9],4.97257896943278e-42,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,5,0.59 [0.49-0.7],1.50212386918368e-08,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GSTA1,Glutathione S-transferase A1,Wald ratio,1,0.43 [0.31-0.6],8.86471273755166e-07,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GRN,Progranulin,Inverse variance weighted,46,1.08 [1.05-1.12],5.29903306406065e-06,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.23 [1.11-1.36],4.66091534016436e-05,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.49 [1.22-1.81],8.60892172683064e-05,trans
Chapter IX Diseases of the circulatory system,I9_IHD,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.18 [1.09-1.29],9.83784204915725e-05,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IFNL1,Interferon lambda-1,Inverse variance weighted,8,1.25 [1.11-1.41],0.000306763830234182,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NTF3,Neurotrophin-3,Inverse variance weighted,11,1.13 [1.05-1.21],0.000497635476013346,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL6,Interleukin-6,Inverse variance weighted,6,0.89 [0.83-0.95],0.000782174933490413,trans
Chapter IX Diseases of the circulatory system,I9_IHD,AREG,Amphiregulin,Inverse variance weighted,5,1.22 [1.08-1.39],0.0017763152527317,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LPO,Lactoperoxidase,Inverse variance weighted,29,1.05 [1.02-1.08],0.00191979453680528,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.97 [0.94-0.99],0.00265943153823286,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FUOM,Fucose mutarotase,Inverse variance weighted,6,1.2 [1.07-1.36],0.00278781377967398,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LPL,Lipoprotein lipase,Inverse variance weighted,8,0.72 [0.58-0.9],0.00332958085257178,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,20,1.08 [1.03-1.14],0.00337925637306772,trans
Chapter IX Diseases of the circulatory system,I9_IHD,POMC,Pro-opiomelanocortin,Inverse variance weighted,15,0.9 [0.84-0.97],0.00407723789133908,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MSLN,Mesothelin,Inverse variance weighted,11,1.17 [1.05-1.3],0.00454706388141966,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.88 [0.8-0.96],0.00499951909939654,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,1.64 [1.16-2.33],0.00526081200057969,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,11,1.17 [1.05-1.31],0.00558599630268114,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,0.87 [0.79-0.96],0.00604281658327774,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.79 [0.67-0.94],0.00618680160739959,trans
Chapter IX Diseases of the circulatory system,I9_IHD,VWC2,Brorin,Inverse variance weighted,12,1.13 [1.03-1.24],0.00696282289783135,trans
Chapter IX Diseases of the circulatory system,I9_IHD,APOL1,Apolipoprotein L1,Inverse variance weighted,46,1.04 [1.01-1.08],0.00702265484494935,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.82 [0.7-0.95],0.00763227303648428,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.09 [1.02-1.17],0.00840319667069991,trans
Chapter IX Diseases of the circulatory system,I9_IHD,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.96 [0.93-0.99],0.00861127301960139,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HEPH,Hephaestin,Inverse variance weighted,6,0.92 [0.87-0.98],0.0106695129981566,trans
Chapter IX Diseases of the circulatory system,I9_IHD,APOD,Apolipoprotein D,Inverse variance weighted,9,0.68 [0.5-0.91],0.0107698610580334,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MMP3,Stromelysin-1,Inverse variance weighted,4,1.45 [1.09-1.93],0.0115046132370683,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.13 [1.03-1.24],0.0116317408909012,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.15 [1.03-1.29],0.0129336132378864,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PALM2,Paralemmin-2,Inverse variance weighted,9,1.07 [1.01-1.13],0.0140220290779152,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.77 [0.63-0.95],0.0141389243494257,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,1.04 [1.01-1.07],0.0155179095972264,trans
Chapter IX Diseases of the circulatory system,I9_IHD,C7,Complement component C7,Inverse variance weighted,26,1.04 [1.01-1.08],0.0171284717459388,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ANG,Angiogenin,Inverse variance weighted,8,1.28 [1.04-1.57],0.0187303964003592,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TMPRSS15,Enteropeptidase,Inverse variance weighted,11,0.93 [0.88-0.99],0.0192974789853297,trans
Chapter IX Diseases of the circulatory system,I9_IHD,WNT9A,Protein Wnt-9a,Wald ratio,1,1.6 [1.08-2.37],0.0194631197775258,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.33 [1.05-1.69],0.0195481161736879,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FGA,Fibrinogen alpha chain,Inverse variance weighted,6,1.33 [1.05-1.69],0.0196066099960222,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.95 [0.91-0.99],0.0202209968420487,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.9 [0.82-0.98],0.0202843357485166,trans
Chapter IX Diseases of the circulatory system,I9_IHD,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.49 [1.06-2.1],0.0213282175359834,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.44 [1.05-1.97],0.0219364001376316,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ADIPOQ,Adiponectin,Inverse variance weighted,25,0.92 [0.85-0.99],0.0219917264604882,trans
Chapter IX Diseases of the circulatory system,I9_IHD,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,1.16 [1.02-1.33],0.0222573088442251,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.86 [0.76-0.98],0.0226991868014223,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DCN,Decorin,Inverse variance weighted,2,0.75 [0.59-0.96],0.0227033590806581,trans
Chapter IX Diseases of the circulatory system,I9_IHD,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Wald ratio,1,1.48 [1.06-2.09],0.0233233344628796,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,0.88 [0.79-0.99],0.025961537065524,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.24 [1.03-1.51],0.0269597295830426,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CPM,Carboxypeptidase M,Inverse variance weighted,19,1.12 [1.01-1.23],0.0274529475632852,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.81 [0.67-0.98],0.0282147211539579,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.81 [0.67-0.98],0.0283205908016144,trans
Chapter IX Diseases of the circulatory system,I9_IHD,KLB,Beta-klotho,Inverse variance weighted,23,1.07 [1.01-1.13],0.0286235782113732,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.85 [0.74-0.98],0.0288952129195044,trans
Chapter IX Diseases of the circulatory system,I9_IHD,L1CAM,Neural cell adhesion molecule L1,Inverse variance weighted,21,1.1 [1.01-1.21],0.0291935657681801,trans
Chapter IX Diseases of the circulatory system,I9_IHD,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.21 [1.02-1.43],0.0305735965780662,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MB,Myoglobin,Inverse variance weighted,9,0.9 [0.81-0.99],0.0311349460859674,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.27 [1.02-1.59],0.0339588370021296,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,0.92 [0.85-0.99],0.0365870662252685,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.86 [0.75-0.99],0.0369777815033672,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.72 [0.53-0.98],0.0377941331189042,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GNPDA2,Glucosamine-6-phosphate isomerase 2,Inverse variance weighted,7,1.08 [1-1.16],0.0385077545100448,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.2 [1.01-1.42],0.0391133230024979,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,50,1.06 [1-1.12],0.039549162375704,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.05 [1-1.1],0.0397786916799364,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.09 [1-1.18],0.0401012257163812,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.91 [0.82-1],0.0401558611237709,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.83 [0.7-0.99],0.0412360147617579,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,14,0.91 [0.83-1],0.0413225436535287,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,0.88 [0.77-1],0.0417016187071887,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.84 [0.71-0.99],0.043188267645673,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.12 [1-1.26],0.0453767612884163,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.95 [0.9-1],0.0463791726528877,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.04 [1-1.09],0.0463870597177545,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.07 [1-1.16],0.0483988753327638,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,1.02 [1-1.03],0.0505984567685284,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,0.95 [0.91-1],0.0508846730898182,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.88 [0.77-1],0.0517157115437192,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.93 [0.86-1],0.0523542618031075,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.09 [1-1.2],0.0559926016619471,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DARS1,"Aspartate--tRNA ligase, cytoplasmic",Wald ratio,1,0.74 [0.54-1.01],0.0572400098097316,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.89 [0.79-1],0.0578471048588343,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,9,1.1 [1-1.22],0.0582240678086156,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.08 [1-1.16],0.0613996820724195,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CFP,Properdin,Inverse variance weighted,17,0.94 [0.89-1],0.0615827814973199,trans
Chapter IX Diseases of the circulatory system,I9_IHD,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.4 [0.98-1.99],0.0624583978686931,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PRSS2,Trypsin-2,Inverse variance weighted,17,0.95 [0.9-1],0.0627208243898907,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MILR1,Allergin-1,Inverse variance weighted,43,0.98 [0.97-1],0.0642842958910292,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.93 [0.87-1.01],0.0680756689351,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DSC2,Desmocollin-2,Inverse variance weighted,16,0.96 [0.92-1],0.0680919415786334,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SPOCK1,Testican-1,Inverse variance weighted,26,0.93 [0.85-1.01],0.0681416508880988,trans
Chapter IX Diseases of the circulatory system,I9_IHD,AGRP,Agouti-related protein,Inverse variance weighted,16,1.18 [0.99-1.4],0.0684431224047632,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,0.93 [0.86-1.01],0.0707073099942474,trans
Chapter IX Diseases of the circulatory system,I9_IHD,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.96 [0.91-1],0.0717897550940413,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.11 [0.99-1.25],0.072768352507872,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.88 [0.76-1.01],0.0729127679867126,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCN1,CCN family member 1,Inverse variance weighted,6,1.61 [0.96-2.72],0.0733366375506471,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,1.03 [1-1.07],0.0740142719189995,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD83,CD83 antigen,Inverse variance weighted,14,0.91 [0.83-1.01],0.0755570395770075,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,0.97 [0.93-1],0.0810101333095079,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LGALS4,Galectin-4,Inverse variance weighted,15,0.97 [0.93-1],0.0822943565785833,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PI3,Elafin,Inverse variance weighted,18,1.04 [0.99-1.1],0.083406888569583,trans
Chapter IX Diseases of the circulatory system,I9_IHD,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.09 [0.99-1.21],0.0840639341530808,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.98 [0.96-1],0.084777779658571,trans
Chapter IX Diseases of the circulatory system,I9_IHD,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,0.92 [0.83-1.01],0.0848950038531496,trans
Chapter IX Diseases of the circulatory system,I9_IHD,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.15 [0.98-1.36],0.0902251453381616,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.86 [0.73-1.02],0.0909397348168442,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.87 [0.74-1.02],0.0934840390447628,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SPON2,Spondin-2,Inverse variance weighted,3,1.18 [0.97-1.42],0.0941819913764529,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.8 [0.62-1.04],0.0961234515479618,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.06 [0.99-1.14],0.0971465921452354,trans
Chapter IX Diseases of the circulatory system,I9_IHD,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,0.84 [0.68-1.03],0.0973488225603788,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.86 [0.73-1.03],0.0976363968414827,trans
Chapter IX Diseases of the circulatory system,I9_IHD,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.1 [0.98-1.24],0.0985495256205855,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.81 [0.63-1.04],0.100076873095025,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SEPTIN8,Septin-8,Inverse variance weighted,4,1.11 [0.98-1.26],0.100170761422043,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.28 [0.95-1.72],0.101158617367262,trans
Chapter IX Diseases of the circulatory system,I9_IHD,APOA1,Apolipoprotein A-I,Inverse variance weighted,13,0.85 [0.7-1.03],0.102353824366292,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.81 [0.62-1.05],0.107455995306096,trans
Chapter IX Diseases of the circulatory system,I9_IHD,KLK14,Kallikrein-14,Inverse variance weighted,15,1.07 [0.99-1.16],0.110753128942137,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,0.88 [0.76-1.03],0.111226936422308,trans
Chapter IX Diseases of the circulatory system,I9_IHD,OGN,Mimecan,Inverse variance weighted,37,0.97 [0.94-1.01],0.111259070545247,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.02 [0.99-1.06],0.112084366992639,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.06 [0.99-1.14],0.115165720471905,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GSN,Gelsolin,Inverse variance weighted,7,1.16 [0.96-1.39],0.116113267378863,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LMNB2,Lamin-B2,Inverse variance weighted,8,1.09 [0.98-1.21],0.11725613217832,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.05 [0.99-1.13],0.119601238913031,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.23 [0.95-1.58],0.119688634421866,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.89 [0.76-1.03],0.122402515380294,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RETN,Resistin,Inverse variance weighted,19,0.94 [0.87-1.02],0.123164994985791,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.94 [0.86-1.02],0.123472587066131,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LDLR,Low-density lipoprotein receptor,Inverse variance weighted,17,1.12 [0.97-1.28],0.123508131127725,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.91 [0.81-1.02],0.123566233537215,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.12 [0.97-1.3],0.124938005417607,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,0.95 [0.88-1.02],0.125536896754231,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,1.15 [0.96-1.38],0.126678843174044,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.87 [0.72-1.04],0.132441253520243,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,4,0.9 [0.78-1.03],0.133800634252947,trans
Chapter IX Diseases of the circulatory system,I9_IHD,BCAN,Brevican core protein,Inverse variance weighted,12,1.1 [0.97-1.25],0.137122998315284,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,1.06 [0.98-1.13],0.138142432051043,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ITGAM,Integrin alpha-M,Inverse variance weighted,12,1.07 [0.98-1.17],0.139210905616341,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,1.19 [0.94-1.49],0.1406069610135,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,0.9 [0.77-1.04],0.140977499473926,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MARCO,Macrophage receptor MARCO,Inverse variance weighted,27,1.06 [0.98-1.14],0.142559344745843,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.21 [0.94-1.57],0.143559796693509,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MMP8,Neutrophil collagenase,Inverse variance weighted,10,1.05 [0.98-1.13],0.145563654791514,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ANXA2,Annexin A2,Inverse variance weighted,2,0.8 [0.59-1.08],0.146073552510525,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.88 [0.75-1.04],0.146279883119758,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,0.88 [0.74-1.05],0.147174063348717,trans
Chapter IX Diseases of the circulatory system,I9_IHD,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.92 [0.83-1.03],0.147903253072289,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MET,Hepatocyte growth factor receptor,Inverse variance weighted,21,1.07 [0.98-1.17],0.152146037308182,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,1.06 [0.98-1.16],0.155761008695391,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,Inverse variance weighted,11,1.06 [0.98-1.16],0.156700778030894,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SDC1,Syndecan-1,Inverse variance weighted,12,1.09 [0.97-1.23],0.157564166389955,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.92 [0.82-1.03],0.158006062178481,trans
Chapter IX Diseases of the circulatory system,I9_IHD,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.88 [0.74-1.05],0.15994872522509,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ACE,Angiotensin-converting enzyme,Inverse variance weighted,27,1.02 [0.99-1.05],0.161550374191703,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.05 [0.98-1.14],0.161882787739071,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.08 [0.97-1.21],0.165888901823752,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,59,1.01 [0.99-1.03],0.168039659060838,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.19 [0.93-1.53],0.17255444423255,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.15 [0.94-1.41],0.173493682596909,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,1.08 [0.97-1.2],0.174984087176598,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RTBDN,Retbindin,Inverse variance weighted,2,1.49 [0.84-2.67],0.176078281071934,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.1 [0.96-1.25],0.176498405244311,trans
Chapter IX Diseases of the circulatory system,I9_IHD,OCLN,Occludin,Inverse variance weighted,2,1.15 [0.94-1.4],0.177073038182416,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,0.95 [0.88-1.02],0.181542558263823,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CNTN5,Contactin-5,Inverse variance weighted,22,1.04 [0.98-1.1],0.183426686026574,trans
Chapter IX Diseases of the circulatory system,I9_IHD,OSM,Oncostatin-M,Inverse variance weighted,6,1.06 [0.97-1.16],0.184795503140341,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD276,CD276 antigen,Inverse variance weighted,24,0.96 [0.91-1.02],0.187991988066127,trans
Chapter IX Diseases of the circulatory system,I9_IHD,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.15 [0.93-1.42],0.188559404369496,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.07 [0.97-1.18],0.188819054534037,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.09 [0.96-1.25],0.189747411147151,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.97 [0.93-1.01],0.190212324834839,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.87 [0.7-1.07],0.191541381098814,trans
Chapter IX Diseases of the circulatory system,I9_IHD,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,0.95 [0.88-1.03],0.193486290897693,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.12 [0.94-1.33],0.194318073618066,trans
Chapter IX Diseases of the circulatory system,I9_IHD,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.16 [0.93-1.46],0.19511792268802,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.91 [0.8-1.05],0.196726459755057,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,22,1.04 [0.98-1.11],0.200151750972181,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CHGA,Chromogranin-A,Inverse variance weighted,5,0.93 [0.84-1.04],0.200338761157973,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.03 [0.98-1.08],0.20092585404853,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL19,C-C motif chemokine 19,Inverse variance weighted,4,1.16 [0.92-1.46],0.202146290258772,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.11 [0.94-1.31],0.203845178010578,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PTH,Parathyroid hormone,Inverse variance weighted,11,1.15 [0.93-1.44],0.204585672304088,trans
Chapter IX Diseases of the circulatory system,I9_IHD,VSNL1,Visinin-like protein 1,Inverse variance weighted,9,0.96 [0.91-1.02],0.206443172256156,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,0.95 [0.89-1.03],0.206737384620154,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,0.96 [0.9-1.02],0.209859605817958,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD302,CD302 antigen,Inverse variance weighted,11,0.93 [0.83-1.04],0.210063738582482,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,18,1.02 [0.99-1.06],0.210329334353383,trans
Chapter IX Diseases of the circulatory system,I9_IHD,F10,Coagulation factor X,Inverse variance weighted,11,0.95 [0.89-1.03],0.210376592667209,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL17,C-C motif chemokine 17,Inverse variance weighted,27,0.98 [0.95-1.01],0.212167019792002,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.08 [0.96-1.21],0.214574403737697,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.84 [0.64-1.11],0.216111128596821,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,1.43 [0.81-2.53],0.216883125459501,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.13 [0.93-1.39],0.22487665466209,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PCDH17,Protocadherin-17,Inverse variance weighted,44,0.98 [0.96-1.01],0.225756773021473,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.13 [0.93-1.38],0.22730603721127,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ITGA5,Integrin alpha-5,Inverse variance weighted,18,0.93 [0.83-1.05],0.230060208064324,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EPO,Erythropoietin,Inverse variance weighted,11,0.95 [0.87-1.03],0.231512583855231,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CPE,Carboxypeptidase E,Inverse variance weighted,10,0.92 [0.79-1.06],0.232095288689635,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ARHGAP1,Rho GTPase-activating protein 1,Inverse variance weighted,4,1.11 [0.93-1.33],0.235854136096653,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,0.92 [0.8-1.06],0.237297433182721,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.02 [0.99-1.06],0.238496219607333,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.29 [0.85-1.95],0.238896885896233,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.05 [0.97-1.14],0.241150080534369,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.02 [0.99-1.04],0.250568584487786,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.05 [0.97-1.15],0.250677969697437,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Inverse variance weighted,6,0.92 [0.8-1.06],0.251252800843252,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,25,0.96 [0.89-1.03],0.25366905071635,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,32,0.97 [0.91-1.03],0.254672979103449,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.03 [0.98-1.1],0.257226869923368,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.05 [0.97-1.14],0.257359850215671,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PRND,Prion-like protein doppel,Inverse variance weighted,15,0.96 [0.89-1.03],0.257887677408699,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PENK,Proenkephalin-A,Inverse variance weighted,15,1.05 [0.96-1.15],0.258021694365204,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.92 [0.8-1.06],0.259570618191601,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,0.94 [0.84-1.05],0.263097777037039,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,5,1.12 [0.92-1.38],0.263762010391443,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IDS,Iduronate 2-sulfatase,Inverse variance weighted,3,1.04 [0.97-1.13],0.26460315100968,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SERPINE1,Plasminogen activator inhibitor 1,Inverse variance weighted,5,1.13 [0.91-1.4],0.267148487857762,trans
Chapter IX Diseases of the circulatory system,I9_IHD,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.96 [0.89-1.03],0.270560545825608,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SERPINB8,Serpin B8,Inverse variance weighted,29,1.01 [0.99-1.03],0.275452666222436,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.09 [0.93-1.27],0.276899493623738,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.07 [0.95-1.2],0.281062799086247,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.94 [0.84-1.05],0.281262449526377,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PROK1,Prokineticin-1,Inverse variance weighted,4,1.13 [0.9-1.42],0.282826405240764,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.18 [0.87-1.59],0.283886169122642,trans
Chapter IX Diseases of the circulatory system,I9_IHD,KLK8,Kallikrein-8,Inverse variance weighted,5,0.86 [0.66-1.13],0.28762073925174,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LIPF,Gastric triacylglycerol lipase,Inverse variance weighted,24,1.03 [0.98-1.07],0.289263455789445,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Wald ratio,1,1.22 [0.84-1.76],0.289529892443725,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.08 [0.93-1.26],0.292133934651874,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.91 [0.75-1.09],0.292959737654884,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.09 [0.93-1.28],0.295282396804336,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PROC,Vitamin K-dependent protein C,Inverse variance weighted,40,0.98 [0.94-1.02],0.297074377631756,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,0.97 [0.93-1.02],0.29752620689325,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.05 [0.96-1.15],0.301704944917941,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.07 [0.94-1.2],0.302040389886639,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EGF,Pro-epidermal growth factor,Wald ratio,1,0.8 [0.51-1.23],0.304941468016688,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.86 [0.65-1.14],0.305365035325675,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.03 [0.98-1.08],0.308149910274601,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TCOF1,Treacle protein,Wald ratio,1,1.18 [0.85-1.64],0.309713336031291,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL17C,Interleukin-17C,Inverse variance weighted,5,1.07 [0.94-1.23],0.312693341940547,trans
Chapter IX Diseases of the circulatory system,I9_IHD,F11R,Junctional adhesion molecule A,Inverse variance weighted,3,1.16 [0.87-1.55],0.314855160573899,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.96 [0.89-1.04],0.318301775326149,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MENT,Protein MENT,Inverse variance weighted,28,1.03 [0.97-1.1],0.31861293820953,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,14,0.94 [0.83-1.06],0.318651543991431,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.03 [0.97-1.1],0.31958407944434,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.06 [0.95-1.18],0.320868919715883,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.16 [0.86-1.57],0.321648859378164,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.89 [0.7-1.12],0.322174965802721,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.88 [0.69-1.13],0.322761074447776,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,8,0.96 [0.89-1.04],0.323013319581396,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.06 [0.94-1.2],0.323151272164409,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.08 [0.93-1.24],0.323959909978532,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FABP6,Gastrotropin,Inverse variance weighted,4,0.88 [0.67-1.14],0.325443501534659,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,0.97 [0.9-1.03],0.326022603415966,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CAPG,Macrophage-capping protein,Wald ratio,1,1.14 [0.88-1.48],0.327519636010112,trans
Chapter IX Diseases of the circulatory system,I9_IHD,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,1.03 [0.97-1.08],0.327954010655486,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CTSD,Cathepsin D,Inverse variance weighted,7,1.07 [0.93-1.24],0.328172240058541,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1.02 [0.98-1.07],0.328931456246853,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EGLN1,Egl nine homolog 1,Wald ratio,1,1.18 [0.85-1.63],0.331680753040144,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SPINK6,Serine protease inhibitor Kazal-type 6,Wald ratio,1,1.18 [0.85-1.63],0.331979121044218,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.09 [0.91-1.31],0.335542536543304,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD40LG,CD40 ligand,Inverse variance weighted,3,1.06 [0.94-1.18],0.336335141504821,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL5,C-X-C motif chemokine 5,Inverse variance weighted,10,1.07 [0.93-1.23],0.338388545718222,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.96 [0.87-1.05],0.338897317243039,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL8,C-C motif chemokine 8,Inverse variance weighted,42,0.99 [0.97-1.01],0.33971355793517,trans
Chapter IX Diseases of the circulatory system,I9_IHD,APOE,Apolipoprotein E,Inverse variance weighted,6,1.06 [0.94-1.19],0.340439086177748,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SIAE,Sialate O-acetylesterase,Inverse variance weighted,6,1.07 [0.93-1.24],0.34046437192331,trans
Chapter IX Diseases of the circulatory system,I9_IHD,XG,Glycoprotein Xg,Inverse variance weighted,2,0.89 [0.71-1.13],0.343354705948577,trans
Chapter IX Diseases of the circulatory system,I9_IHD,INHBC,Inhibin beta C chain,Inverse variance weighted,12,1.06 [0.94-1.19],0.344153059654386,trans
Chapter IX Diseases of the circulatory system,I9_IHD,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.06 [0.94-1.2],0.346741212093252,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MCAM,Cell surface glycoprotein MUC18,Inverse variance weighted,11,1.05 [0.95-1.16],0.347522904845886,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GDF2,Growth/differentiation factor 2,Inverse variance weighted,31,0.97 [0.91-1.03],0.351394058580388,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.01 [0.98-1.05],0.355192630492823,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.35 [0.71-2.54],0.356425447843819,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.95 [0.85-1.06],0.358745466092145,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MPO,Myeloperoxidase,Inverse variance weighted,17,1.02 [0.97-1.08],0.359298964361856,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.92 [0.77-1.1],0.361018522063084,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TBL1X,F-box-like/WD repeat-containing protein TBL1X,Wald ratio,1,0.87 [0.65-1.17],0.362242916179577,trans
Chapter IX Diseases of the circulatory system,I9_IHD,VEGFC,Vascular endothelial growth factor C,Inverse variance weighted,6,0.93 [0.78-1.09],0.362841686938338,trans
Chapter IX Diseases of the circulatory system,I9_IHD,AGRN,Agrin,Inverse variance weighted,14,1.05 [0.94-1.18],0.363322739769442,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LEP,Leptin,Inverse variance weighted,4,1.22 [0.79-1.87],0.365461621496355,trans
Chapter IX Diseases of the circulatory system,I9_IHD,STC2,Stanniocalcin-2,Inverse variance weighted,10,1.11 [0.88-1.4],0.366154197971608,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NECTIN4,Nectin-4,Inverse variance weighted,4,1.09 [0.9-1.33],0.36617969299113,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.07 [0.93-1.22],0.366346564390722,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL19,Interleukin-19,Inverse variance weighted,10,1.02 [0.98-1.06],0.367530271134108,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,0.95 [0.84-1.07],0.368535167912566,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MVK,Mevalonate kinase,Wald ratio,1,0.72 [0.36-1.47],0.368786400283712,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,1.05 [0.95-1.16],0.369218066730996,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.92 [0.76-1.11],0.37596929969599,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ACAN,Aggrecan core protein,Inverse variance weighted,30,1.03 [0.96-1.11],0.377675711011829,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL11,Eotaxin,Inverse variance weighted,11,1.03 [0.97-1.09],0.380525718878419,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.07 [0.92-1.23],0.381255712815849,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,0.98 [0.93-1.03],0.382756560370752,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL15,Interleukin-15,Inverse variance weighted,35,0.98 [0.92-1.03],0.382784866075799,trans
Chapter IX Diseases of the circulatory system,I9_IHD,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.09 [0.9-1.33],0.383004852928278,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.04 [0.95-1.14],0.384270472471633,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SIT1,Signaling threshold-regulating transmembrane adapter 1,Inverse variance weighted,7,1.09 [0.89-1.34],0.384381785434603,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.24 [0.76-2.01],0.386251483777662,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.93 [0.78-1.1],0.38641387041975,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.1 [0.89-1.36],0.388985984858216,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL13RA1,Interleukin-13 receptor subunit alpha-1,Inverse variance weighted,3,0.97 [0.89-1.05],0.389279884084306,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",Inverse variance weighted,18,1.02 [0.97-1.08],0.390482520108077,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SPON1,Spondin-1,Inverse variance weighted,4,1.06 [0.92-1.23],0.391562549804622,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD27,CD27 antigen,Inverse variance weighted,9,1.06 [0.92-1.22],0.391692003353505,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PLTP,Phospholipid transfer protein,Inverse variance weighted,30,1.02 [0.97-1.08],0.392967666297115,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.15 [0.83-1.59],0.394174424426537,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.96 [0.86-1.06],0.396647909701946,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.22 [0.77-1.96],0.396823932028532,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SELL,L-selectin,Inverse variance weighted,11,0.96 [0.88-1.05],0.398185522864064,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,1.02 [0.97-1.08],0.399925342366747,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HBEGF,Proheparin-binding EGF-like growth factor,Inverse variance weighted,22,0.97 [0.91-1.04],0.40340544122126,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DEFB4A_DEFB4B,Beta-defensin 4A,Inverse variance weighted,7,1.12 [0.86-1.48],0.403568484228963,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SCT,Secretin,Inverse variance weighted,5,1.06 [0.93-1.21],0.404132129561367,trans
Chapter IX Diseases of the circulatory system,I9_IHD,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.02 [0.97-1.07],0.40569116465528,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,1.06 [0.92-1.22],0.406826571394162,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.03 [0.96-1.11],0.409046401982174,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GUSB,Beta-glucuronidase,Inverse variance weighted,31,1.03 [0.96-1.1],0.410074433413629,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,1.01 [0.98-1.05],0.410539038545827,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.08 [0.89-1.31],0.411152959447286,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.17 [0.81-1.69],0.413992764960569,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.79 [0.45-1.39],0.415207200338752,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RSPO3,R-spondin-3,Inverse variance weighted,5,0.85 [0.58-1.25],0.415899603676537,trans
Chapter IX Diseases of the circulatory system,I9_IHD,XCL1,Lymphotactin,Inverse variance weighted,15,0.94 [0.8-1.09],0.41884337821641,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MFGE8,Lactadherin,Inverse variance weighted,15,1.08 [0.89-1.31],0.419645558701601,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MDK,Midkine,Inverse variance weighted,14,1.04 [0.94-1.16],0.419998727332407,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CTSL,Cathepsin L1,Inverse variance weighted,29,0.97 [0.91-1.04],0.420274232931942,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TCN2,Transcobalamin-2,Inverse variance weighted,24,1.01 [0.98-1.05],0.420814389190524,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LGMN,Legumain,Inverse variance weighted,22,1.05 [0.94-1.17],0.423519054287032,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.06 [0.92-1.21],0.424393195073217,trans
Chapter IX Diseases of the circulatory system,I9_IHD,BDNF,Brain-derived neurotrophic factor,Inverse variance weighted,5,1.08 [0.9-1.29],0.425080376342936,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.92 [0.75-1.13],0.425132463984584,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.02 [0.97-1.07],0.426734937301859,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FGFBP3,Fibroblast growth factor-binding protein 3,Inverse variance weighted,43,1.02 [0.98-1.06],0.430255069133125,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,0.87 [0.62-1.23],0.432711290768202,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.97 [0.9-1.05],0.437095815730698,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.06 [0.91-1.24],0.442060244268126,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.97 [0.91-1.04],0.44431868415007,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.12 [0.84-1.49],0.444502193502594,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.94 [0.81-1.1],0.445772041254626,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.89 [0.66-1.2],0.446127738422315,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,1.02 [0.96-1.09],0.446666270227523,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,0.87 [0.6-1.25],0.446691798872509,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.06 [0.91-1.24],0.448122051646448,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.96 [0.86-1.07],0.448220110166659,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NFASC,Neurofascin,Inverse variance weighted,6,0.91 [0.71-1.16],0.451881140967597,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.86 [0.58-1.28],0.453917680571772,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,38,1.01 [0.98-1.05],0.459460438309985,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,1.07 [0.9-1.28],0.460030430480364,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,11,1.03 [0.95-1.12],0.462193529320064,trans
Chapter IX Diseases of the circulatory system,I9_IHD,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.04 [0.94-1.14],0.462970486533506,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LGALS9,Galectin-9,Inverse variance weighted,36,0.99 [0.96-1.02],0.462974415883808,trans
Chapter IX Diseases of the circulatory system,I9_IHD,KLKB1,Plasma kallikrein,Inverse variance weighted,20,0.98 [0.92-1.04],0.469755320303112,trans
Chapter IX Diseases of the circulatory system,I9_IHD,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.05 [0.92-1.21],0.470581283245905,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.1 [0.85-1.43],0.472409019981173,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.15 [0.79-1.67],0.472870994079995,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PDGFA,Platelet-derived growth factor subunit A,Inverse variance weighted,4,1.15 [0.78-1.7],0.475427098453267,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.15 [0.78-1.7],0.475876430205251,trans
Chapter IX Diseases of the circulatory system,I9_IHD,F7,Coagulation factor VII,Inverse variance weighted,10,1.03 [0.95-1.12],0.476230119046817,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Wald ratio,1,0.9 [0.67-1.21],0.476734472082889,trans
Chapter IX Diseases of the circulatory system,I9_IHD,F13B,Coagulation factor XIII B chain,Inverse variance weighted,10,1.02 [0.97-1.07],0.477684689377355,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,1.02 [0.96-1.08],0.477896083728963,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,0.97 [0.89-1.05],0.478482648817707,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PDGFB,Platelet-derived growth factor subunit B,Inverse variance weighted,8,1.05 [0.93-1.18],0.4787847722245,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.06 [0.91-1.23],0.48289861494757,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FURIN,Furin,Inverse variance weighted,3,0.94 [0.8-1.11],0.484210255297352,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.93 [0.76-1.14],0.488939582767367,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.99 [0.97-1.01],0.489981853618738,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,0.98 [0.91-1.04],0.492808619257106,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.03 [0.95-1.11],0.493328631375775,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ERBB3,Receptor tyrosine-protein kinase erbB-3,Inverse variance weighted,11,1.05 [0.92-1.2],0.493757603879417,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.2 [0.71-2.05],0.494882321603688,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,0.97 [0.9-1.05],0.497090202422677,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,1.09 [0.85-1.39],0.497322319443411,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HJV,Hemojuvelin,Inverse variance weighted,2,0.92 [0.73-1.17],0.502284770668333,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.08 [0.87-1.33],0.503941523520483,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IDUA,Alpha-L-iduronidase,Inverse variance weighted,18,1.04 [0.92-1.18],0.505174611090429,trans
Chapter IX Diseases of the circulatory system,I9_IHD,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.95 [0.82-1.1],0.507619948264279,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.09 [0.84-1.43],0.507880913250384,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.04 [0.93-1.15],0.509212424294485,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ITGA2,Integrin alpha-2,Inverse variance weighted,13,1.03 [0.94-1.12],0.510266122825872,trans
Chapter IX Diseases of the circulatory system,I9_IHD,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.97 [0.89-1.06],0.51058492703448,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.03 [0.94-1.13],0.512788862631143,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,1.04 [0.93-1.16],0.513397915372567,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.03 [0.95-1.11],0.514144007697277,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.08 [0.86-1.36],0.515213872465142,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD209,CD209 antigen,Inverse variance weighted,34,0.99 [0.96-1.02],0.515907223927357,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.12 [0.79-1.6],0.516400975219627,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.96 [0.83-1.1],0.516675267467533,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.04 [0.93-1.16],0.520026607112327,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.95 [0.82-1.1],0.521758949235189,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.95 [0.83-1.1],0.521840716344817,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CFI,Complement factor I,Wald ratio,1,1.15 [0.75-1.74],0.522517149888739,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD99,CD99 antigen,Inverse variance weighted,4,1.09 [0.84-1.41],0.52270070285446,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LPA,Apolipoprotein(a),Inverse variance weighted,2,1.09 [0.83-1.43],0.525567563019778,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,0.97 [0.88-1.07],0.527164124502631,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.93 [0.73-1.18],0.527225023729804,trans
Chapter IX Diseases of the circulatory system,I9_IHD,BPIFB2,BPI fold-containing family B member 2,Inverse variance weighted,37,0.98 [0.94-1.03],0.528063432029973,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.93 [0.73-1.17],0.529228164407281,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.06 [0.88-1.28],0.530360636443934,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CDH1,Cadherin-1,Inverse variance weighted,16,0.98 [0.94-1.03],0.530568412642767,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GCG,Pro-glucagon,Inverse variance weighted,2,0.93 [0.75-1.16],0.531253525054474,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PRSS8,Prostasin,Inverse variance weighted,14,0.97 [0.89-1.06],0.533374091294342,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,6,0.89 [0.63-1.27],0.535670034514425,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.01 [0.98-1.03],0.539040866333727,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,0.97 [0.9-1.06],0.539076735031616,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.03 [0.94-1.13],0.544088913525369,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,0.99 [0.95-1.03],0.545256851140235,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MASP1,Mannan-binding lectin serine protease 1,Inverse variance weighted,28,0.99 [0.96-1.02],0.546030687052708,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,0.92 [0.7-1.21],0.546955029176828,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LAYN,Layilin,Inverse variance weighted,3,1.08 [0.85-1.37],0.547557272682308,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],Inverse variance weighted,2,1.17 [0.7-1.94],0.549227384275324,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PTN,Pleiotrophin,Inverse variance weighted,3,0.91 [0.67-1.24],0.549562655092763,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD160,CD160 antigen,Inverse variance weighted,24,0.98 [0.91-1.05],0.550568538400914,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.97 [0.86-1.08],0.551124467117206,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NRP1,Neuropilin-1,Inverse variance weighted,14,0.97 [0.88-1.07],0.551783282473306,trans
Chapter IX Diseases of the circulatory system,I9_IHD,S100G,Protein S100-G,Inverse variance weighted,4,1.04 [0.91-1.2],0.551968418485931,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.02 [0.96-1.08],0.553141327831512,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,1.07 [0.86-1.33],0.553770201369676,trans
Chapter IX Diseases of the circulatory system,I9_IHD,COLEC12,Collectin-12,Inverse variance weighted,3,1.15 [0.72-1.86],0.554094042152054,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.97 [0.88-1.07],0.555399056845568,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NUCB2,Nucleobindin-2,Inverse variance weighted,2,1.13 [0.75-1.73],0.555514524484269,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MMP10,Stromelysin-2,Wald ratio,1,0.9 [0.63-1.28],0.556056894067018,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.02 [0.96-1.09],0.557690049725795,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,54,1.01 [0.99-1.03],0.558914863795407,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL3,C-X-C motif chemokine 3,Wald ratio,1,0.92 [0.71-1.2],0.55966663986414,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.08 [0.83-1.41],0.560452739952969,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.09 [0.82-1.45],0.561304576765545,trans
Chapter IX Diseases of the circulatory system,I9_IHD,S100P,Protein S100-P,Inverse variance weighted,4,0.96 [0.82-1.11],0.562471267543415,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CA6,Carbonic anhydrase 6,Inverse variance weighted,20,0.96 [0.84-1.1],0.564717661834886,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MME,Neprilysin,Inverse variance weighted,46,0.99 [0.95-1.03],0.567858100699678,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,19,0.98 [0.93-1.04],0.569653936559965,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.91 [0.64-1.28],0.570725959428636,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CSTB,Cystatin-B,Inverse variance weighted,23,1.01 [0.98-1.04],0.571631739880052,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.02 [0.96-1.08],0.574152937134989,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.95 [0.81-1.12],0.574345706419025,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IGSF9,Protein turtle homolog A,Inverse variance weighted,2,1.06 [0.86-1.3],0.575522506957587,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.96 [0.84-1.11],0.579426823514115,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,4,1.36 [0.46-4.03],0.579471038056553,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1.01 [0.98-1.03],0.579866707622472,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.02 [0.96-1.07],0.583784303981413,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.01 [0.96-1.07],0.585111313678863,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,1.03 [0.92-1.16],0.585262166416658,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GPC5,Glypican-5,Inverse variance weighted,42,0.99 [0.97-1.02],0.586324319080467,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.03 [0.92-1.16],0.587057712827034,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PGF,Placenta growth factor,Inverse variance weighted,5,1.03 [0.92-1.15],0.587757409430118,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.93 [0.72-1.21],0.588232440384563,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,0.97 [0.89-1.07],0.5932045301557,trans
Chapter IX Diseases of the circulatory system,I9_IHD,KLK11,Kallikrein-11,Inverse variance weighted,13,0.98 [0.89-1.07],0.594537803825732,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.01 [0.97-1.05],0.595416055053546,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.02 [0.96-1.08],0.59893847019221,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ANGPT1,Angiopoietin-1,Inverse variance weighted,10,1.03 [0.91-1.17],0.599075043687081,trans
Chapter IX Diseases of the circulatory system,I9_IHD,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.95 [0.78-1.16],0.600962010993502,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.01 [0.97-1.05],0.603257536463856,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CTSO,Cathepsin O,Inverse variance weighted,19,0.97 [0.86-1.09],0.603546644614741,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.02 [0.94-1.12],0.608964931578241,trans
Chapter IX Diseases of the circulatory system,I9_IHD,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,0.99 [0.96-1.03],0.610937759010245,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HAO1,Hydroxyacid oxidase 1,Inverse variance weighted,6,0.95 [0.77-1.17],0.61411767692754,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.03 [0.91-1.17],0.614235142081831,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HEPACAM2,HEPACAM family member 2,Inverse variance weighted,69,1.01 [0.98-1.03],0.614967860696716,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,1.02 [0.95-1.1],0.615451855297613,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.92 [0.67-1.27],0.61566634828386,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CDH2,Cadherin-2,Inverse variance weighted,21,0.97 [0.85-1.11],0.629408662239431,trans
Chapter IX Diseases of the circulatory system,I9_IHD,BSG,Basigin,Inverse variance weighted,6,1.06 [0.84-1.33],0.635950909054379,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.08 [0.77-1.52],0.636800413221744,trans
Chapter IX Diseases of the circulatory system,I9_IHD,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,1.02 [0.95-1.09],0.639555273538593,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.98 [0.89-1.07],0.639741110923873,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MEGF10,Multiple epidermal growth factor-like domains protein 10,Inverse variance weighted,27,0.98 [0.9-1.07],0.639778091157384,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ELN,Elastin,Inverse variance weighted,10,0.94 [0.72-1.23],0.640516283607441,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.96 [0.81-1.14],0.641984234747485,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.01 [0.97-1.04],0.642097685535657,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.96 [0.82-1.13],0.642309271939629,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.97 [0.87-1.09],0.644733684509274,trans
Chapter IX Diseases of the circulatory system,I9_IHD,APCS,Serum amyloid P-component,Inverse variance weighted,3,1.04 [0.88-1.24],0.649112916735363,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,0.97 [0.84-1.11],0.651967008440244,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,7,1.02 [0.94-1.1],0.652120267581867,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CFHR4,Complement factor H-related protein 4,Inverse variance weighted,31,1.01 [0.95-1.08],0.653264426099084,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EGFLAM,Pikachurin,Wald ratio,1,1.11 [0.71-1.74],0.654397606675903,trans
Chapter IX Diseases of the circulatory system,I9_IHD,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,0.97 [0.87-1.09],0.655424808868727,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MMP7,Matrilysin,Wald ratio,1,0.97 [0.85-1.1],0.656890772704068,trans
Chapter IX Diseases of the circulatory system,I9_IHD,C8B,Complement component C8 beta chain,Inverse variance weighted,4,0.98 [0.89-1.08],0.658255795302959,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.96 [0.79-1.16],0.659175105200858,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Wald ratio,1,1.07 [0.8-1.43],0.659335758922052,trans
Chapter IX Diseases of the circulatory system,I9_IHD,THBS2,Thrombospondin-2,Inverse variance weighted,15,1.02 [0.95-1.09],0.661572167133262,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.01 [0.96-1.07],0.663914055385004,trans
Chapter IX Diseases of the circulatory system,I9_IHD,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,1.02 [0.92-1.13],0.666600417807439,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.97 [0.86-1.1],0.667059390342265,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PYY,Peptide YY,Inverse variance weighted,16,0.99 [0.94-1.04],0.667319037785503,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.01 [0.97-1.05],0.668073601854221,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.95 [0.75-1.21],0.669927293212035,trans
Chapter IX Diseases of the circulatory system,I9_IHD,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.03 [0.9-1.18],0.671780917638643,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,20,1.03 [0.9-1.17],0.672559206738605,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GAST,Gastrin,Inverse variance weighted,9,0.97 [0.86-1.1],0.672944024951185,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNN,Tenascin-N,Inverse variance weighted,41,1.01 [0.98-1.03],0.674383593809476,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.98 [0.91-1.06],0.680220351394391,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SERPINA6,Corticosteroid-binding globulin,Inverse variance weighted,4,0.96 [0.81-1.15],0.680574005970831,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,35,0.99 [0.96-1.02],0.684089974718167,trans
Chapter IX Diseases of the circulatory system,I9_IHD,AFP,Alpha-fetoprotein,Inverse variance weighted,67,1.01 [0.97-1.05],0.684320079240101,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCN5,CCN family member 5,Inverse variance weighted,12,0.99 [0.94-1.04],0.684475486568528,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GUCA2A,Guanylin,Inverse variance weighted,7,1.02 [0.91-1.15],0.685836631973649,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,1.01 [0.95-1.08],0.69163309264088,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.04 [0.85-1.28],0.697356797171844,trans
Chapter IX Diseases of the circulatory system,I9_IHD,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.04 [0.84-1.3],0.698285101628689,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CREG1,Protein CREG1,Inverse variance weighted,20,0.99 [0.94-1.04],0.70144522087909,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1.04 [0.85-1.27],0.702276053558043,trans
Chapter IX Diseases of the circulatory system,I9_IHD,F9,Coagulation factor IX,Inverse variance weighted,3,0.97 [0.81-1.15],0.706339642358151,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.02 [0.93-1.12],0.70639028955325,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CLPS,Colipase,Inverse variance weighted,28,0.98 [0.91-1.07],0.70669415641406,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.05 [0.8-1.39],0.707176021185975,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SCG2,Secretogranin-2,Inverse variance weighted,2,1.03 [0.87-1.23],0.708207887781386,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,5,0.98 [0.87-1.1],0.712002543396182,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.01 [0.98-1.04],0.714036192000879,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CTSS,Cathepsin S,Inverse variance weighted,7,1.04 [0.84-1.29],0.716789361612126,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.02 [0.93-1.11],0.718374349909885,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,1.09 [0.68-1.75],0.718730045600096,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,27,1.01 [0.94-1.09],0.719002130587871,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,1 [0.98-1.03],0.719852042138565,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,9,1.02 [0.9-1.16],0.726526282339611,trans
Chapter IX Diseases of the circulatory system,I9_IHD,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.99 [0.94-1.05],0.726898075537362,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.01 [0.94-1.09],0.727030246694794,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CHL1,Neural cell adhesion molecule L1-like protein,Inverse variance weighted,11,0.98 [0.86-1.11],0.731135333987368,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CFH,Complement factor H,Inverse variance weighted,7,0.98 [0.89-1.08],0.732344863962712,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CALB1,Calbindin,Inverse variance weighted,9,1.02 [0.9-1.16],0.735503644731751,trans
Chapter IX Diseases of the circulatory system,I9_IHD,KLK4,Kallikrein-4,Inverse variance weighted,5,0.95 [0.69-1.3],0.735936400355591,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.03 [0.86-1.23],0.736872397931478,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,1.05 [0.81-1.35],0.737059300470165,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL13,C-C motif chemokine 13,Inverse variance weighted,21,0.99 [0.94-1.05],0.737501609707485,trans
Chapter IX Diseases of the circulatory system,I9_IHD,REN,Renin,Inverse variance weighted,8,1.06 [0.75-1.49],0.737640126560927,trans
Chapter IX Diseases of the circulatory system,I9_IHD,UPB1,Beta-ureidopropionase,Wald ratio,1,0.87 [0.38-1.99],0.739000156025908,trans
Chapter IX Diseases of the circulatory system,I9_IHD,THPO,Thrombopoietin,Inverse variance weighted,12,0.99 [0.92-1.06],0.740536108335911,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SCG3,Secretogranin-3,Inverse variance weighted,16,0.99 [0.91-1.07],0.742058485768644,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FBLN2,Fibulin-2,Inverse variance weighted,6,1.04 [0.81-1.34],0.742244136053331,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,20,0.99 [0.94-1.05],0.742385909160443,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.03 [0.85-1.26],0.743257012955729,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IDO1,"Indoleamine 2,3-dioxygenase 1",Inverse variance weighted,17,1.01 [0.94-1.09],0.744290454727934,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,14,1.01 [0.95-1.08],0.747442277560373,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.96 [0.73-1.26],0.751533725823496,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.04 [0.8-1.37],0.758352166251938,trans
Chapter IX Diseases of the circulatory system,I9_IHD,P4HB,Protein disulfide-isomerase,Inverse variance weighted,4,0.95 [0.67-1.34],0.759553361691719,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CHGB,Secretogranin-1,Inverse variance weighted,7,0.98 [0.87-1.11],0.766887693438501,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NRP2,Neuropilin-2,Inverse variance weighted,14,1.02 [0.91-1.14],0.768741092768497,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.94 [0.62-1.42],0.770167932001593,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MUC13,Mucin-13,Inverse variance weighted,3,0.92 [0.52-1.63],0.770185425491155,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.01 [0.97-1.05],0.770533400765345,trans
Chapter IX Diseases of the circulatory system,I9_IHD,BPIFA2,BPI fold-containing family A member 2,Inverse variance weighted,40,1.01 [0.96-1.06],0.773157411898129,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.99 [0.9-1.08],0.773188538483246,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LGALS3,Galectin-3,Inverse variance weighted,15,0.99 [0.89-1.09],0.77439796488296,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DPT,Dermatopontin,Inverse variance weighted,4,1.02 [0.87-1.21],0.775050778194037,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CLEC4A,C-type lectin domain family 4 member A,Inverse variance weighted,16,1.02 [0.88-1.2],0.775894894162859,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,0.99 [0.91-1.07],0.776929213885089,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GPR15L,Protein GPR15L,Inverse variance weighted,13,0.99 [0.95-1.04],0.780293323935995,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,1 [0.98-1.03],0.783437683560735,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.03 [0.83-1.29],0.784029650490051,trans
Chapter IX Diseases of the circulatory system,I9_IHD,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.03 [0.83-1.28],0.784264421995491,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,1.04 [0.76-1.43],0.785381717036956,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HMOX1,Heme oxygenase 1,Inverse variance weighted,20,1.01 [0.94-1.09],0.787147861216503,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1 [0.97-1.03],0.789356505810214,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,0.91 [0.45-1.83],0.789472461492377,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CFD,Complement factor D,Wald ratio,1,1.04 [0.78-1.4],0.791870222918948,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PALM,Paralemmin-1,Inverse variance weighted,4,0.97 [0.79-1.19],0.792335556805303,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GHRL,Appetite-regulating hormone,Inverse variance weighted,14,0.99 [0.89-1.1],0.796915448283563,trans
Chapter IX Diseases of the circulatory system,I9_IHD,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.99 [0.89-1.09],0.79810211841058,trans
Chapter IX Diseases of the circulatory system,I9_IHD,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,1 [0.96-1.03],0.801508629436606,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.02 [0.89-1.17],0.80230345541201,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.99 [0.91-1.07],0.804279734541179,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,8,1.02 [0.85-1.23],0.807825280976922,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.01 [0.92-1.11],0.809705319542766,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.03 [0.84-1.26],0.812094979822517,trans
Chapter IX Diseases of the circulatory system,I9_IHD,UMOD,Uromodulin,Inverse variance weighted,34,1.01 [0.94-1.07],0.816713210247511,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CST3,Cystatin-C,Inverse variance weighted,3,0.97 [0.72-1.3],0.818785548034277,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,20,0.99 [0.92-1.07],0.822876718853098,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.01 [0.9-1.15],0.826174076647471,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.02 [0.85-1.22],0.828344695033903,trans
Chapter IX Diseases of the circulatory system,I9_IHD,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,17,1.01 [0.94-1.09],0.82845141251624,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CLEC3B,Tetranectin,Inverse variance weighted,2,0.97 [0.76-1.25],0.83531480582915,trans
Chapter IX Diseases of the circulatory system,I9_IHD,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",Inverse variance weighted,17,1 [0.96-1.05],0.838185652399229,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,11,1.01 [0.94-1.07],0.840097627897059,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1 [0.96-1.03],0.842364517015382,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,12,1.02 [0.85-1.22],0.843342833339648,trans
Chapter IX Diseases of the circulatory system,I9_IHD,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,1.02 [0.84-1.24],0.843753027061407,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,1 [0.96-1.03],0.846132626483119,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Inverse variance weighted,14,0.99 [0.86-1.13],0.847914015393689,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD58,Lymphocyte function-associated antigen 3,Inverse variance weighted,6,1.01 [0.92-1.11],0.849269919921644,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.98 [0.81-1.2],0.850147480685579,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.95 [0.56-1.62],0.850477517891197,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,1.04 [0.68-1.59],0.857232039550775,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,11,1.01 [0.9-1.13],0.859700383854468,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PKD1,Polycystin-1,Inverse variance weighted,12,0.99 [0.85-1.14],0.860285729861095,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,0.99 [0.93-1.07],0.866764800564791,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.99 [0.93-1.06],0.867601734199236,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ITGA6,Integrin alpha-6,Inverse variance weighted,7,0.99 [0.91-1.08],0.868268590392212,trans
Chapter IX Diseases of the circulatory system,I9_IHD,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.02 [0.85-1.22],0.869361431115725,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SPP1,Osteopontin,Inverse variance weighted,13,0.99 [0.86-1.14],0.87036000353779,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD34,Hematopoietic progenitor cell antigen CD34,Inverse variance weighted,2,0.97 [0.67-1.4],0.872054686939404,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.99 [0.93-1.07],0.875410590243661,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.02 [0.77-1.36],0.876455435165783,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RSPO1,R-spondin-1,Inverse variance weighted,8,0.99 [0.91-1.09],0.878538492033931,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,Inverse variance weighted,48,1 [0.96-1.04],0.882899045354318,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.98 [0.78-1.23],0.883077194447768,trans
Chapter IX Diseases of the circulatory system,I9_IHD,AMBP,Protein AMBP,Inverse variance weighted,5,0.99 [0.86-1.14],0.884283003421262,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ROBO2,Roundabout homolog 2,Inverse variance weighted,6,0.99 [0.86-1.14],0.884596701783482,trans
Chapter IX Diseases of the circulatory system,I9_IHD,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,25,1.01 [0.93-1.09],0.884871230933072,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,10,0.98 [0.77-1.26],0.891214133203909,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.01 [0.91-1.11],0.891762901026108,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GAL,Galanin peptides,Inverse variance weighted,49,1 [0.93-1.07],0.891913504121586,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,0.99 [0.84-1.17],0.896264062918498,trans
Chapter IX Diseases of the circulatory system,I9_IHD,XPNPEP2,Xaa-Pro aminopeptidase 2,Inverse variance weighted,20,1 [0.93-1.09],0.907404047899726,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,0.99 [0.91-1.08],0.908440566152976,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GHR,Growth hormone receptor,Inverse variance weighted,26,1 [0.91-1.08],0.908653287452858,trans
Chapter IX Diseases of the circulatory system,I9_IHD,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.98 [0.74-1.3],0.908909173324846,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.98 [0.76-1.28],0.909745914494096,trans
Chapter IX Diseases of the circulatory system,I9_IHD,APOF,Apolipoprotein F,Inverse variance weighted,8,0.98 [0.73-1.33],0.911618530720043,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,27,1 [0.98-1.02],0.916161056240893,trans
Chapter IX Diseases of the circulatory system,I9_IHD,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1 [0.93-1.06],0.916965351725104,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1 [0.93-1.09],0.917714672800171,trans
Chapter IX Diseases of the circulatory system,I9_IHD,POF1B,Protein POF1B,Inverse variance weighted,4,1.01 [0.82-1.25],0.921985790885682,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PGA4,Pepsin A-4,Inverse variance weighted,7,1.01 [0.85-1.2],0.925465888930466,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.99 [0.85-1.16],0.927923144881857,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.99 [0.73-1.34],0.928511375930482,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FAM3D,Protein FAM3D,Inverse variance weighted,38,1 [0.96-1.03],0.930422069724332,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,1.01 [0.87-1.17],0.930998356637443,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.01 [0.8-1.27],0.931116657327055,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,1 [0.97-1.04],0.931456045671684,trans
Chapter IX Diseases of the circulatory system,I9_IHD,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.99 [0.87-1.14],0.932419252368594,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,1 [0.91-1.09],0.936293240351812,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,0.99 [0.79-1.24],0.936304689575937,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCN4,CCN family member 4,Inverse variance weighted,29,1 [0.96-1.04],0.937125088621171,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.01 [0.84-1.2],0.937413652997367,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1 [0.9-1.1],0.93750156200555,trans
Chapter IX Diseases of the circulatory system,I9_IHD,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.01 [0.74-1.39],0.938138469287117,trans
Chapter IX Diseases of the circulatory system,I9_IHD,NECTIN2,Nectin-2,Inverse variance weighted,3,0.99 [0.74-1.32],0.938825606444549,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PLA2G1B,Phospholipase A2,Inverse variance weighted,20,1 [0.93-1.07],0.941472688603017,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PSAP,Prosaposin,Inverse variance weighted,13,1 [0.94-1.06],0.942449327063447,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CFC1,Cryptic protein,Inverse variance weighted,11,1 [0.9-1.13],0.943063625766096,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,0.99 [0.73-1.34],0.943300477020152,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GLA,Alpha-galactosidase A,Inverse variance weighted,2,1.01 [0.79-1.29],0.946059423133945,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1 [0.98-1.03],0.946113143202575,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1 [0.89-1.12],0.946471028360456,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1 [0.87-1.14],0.948617530555079,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1 [0.92-1.08],0.949374387845421,trans
Chapter IX Diseases of the circulatory system,I9_IHD,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,1 [0.97-1.04],0.952801553208075,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1 [0.88-1.13],0.953700276643712,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1 [0.88-1.14],0.953710088792358,trans
Chapter IX Diseases of the circulatory system,I9_IHD,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1 [0.92-1.08],0.954043690771545,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,1 [0.9-1.12],0.955411511315996,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.01 [0.75-1.36],0.957395764260136,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SHISA5,Protein shisa-5,Inverse variance weighted,12,1 [0.9-1.11],0.957705356083672,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SPARC,SPARC,Inverse variance weighted,7,1 [0.87-1.14],0.957711574067754,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL17D,Interleukin-17D,Inverse variance weighted,2,0.97 [0.35-2.72],0.958591798969314,trans
Chapter IX Diseases of the circulatory system,I9_IHD,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1 [0.92-1.09],0.959300983402082,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CTSB,Cathepsin B,Inverse variance weighted,28,1 [0.95-1.06],0.962597861787545,trans
Chapter IX Diseases of the circulatory system,I9_IHD,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,1 [0.86-1.16],0.962897725967052,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.99 [0.76-1.3],0.964981844366239,trans
Chapter IX Diseases of the circulatory system,I9_IHD,VWF,von Willebrand factor,Inverse variance weighted,6,1 [0.88-1.13],0.965025104076701,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1 [0.95-1.05],0.966504144896879,trans
Chapter IX Diseases of the circulatory system,I9_IHD,IL18,Interleukin-18,Inverse variance weighted,26,1 [0.95-1.05],0.966713416801336,trans
Chapter IX Diseases of the circulatory system,I9_IHD,FASLG,Tumor necrosis factor ligand superfamily member 6,Inverse variance weighted,53,1 [0.94-1.06],0.96857848423083,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,1 [0.9-1.11],0.969650246912098,trans
Chapter IX Diseases of the circulatory system,I9_IHD,S100A4,Protein S100-A4,Inverse variance weighted,2,1 [0.8-1.24],0.977175048958794,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1 [0.95-1.05],0.978703719611729,trans
Chapter IX Diseases of the circulatory system,I9_IHD,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,37,1 [0.92-1.08],0.979311974419335,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1 [0.93-1.07],0.98231461162897,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CCN3,CCN family member 3,Inverse variance weighted,17,1 [0.92-1.09],0.982396670846139,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1 [0.71-1.41],0.985590278930874,trans
Chapter IX Diseases of the circulatory system,I9_IHD,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,1 [0.9-1.11],0.987149684420941,trans
Chapter IX Diseases of the circulatory system,I9_IHD,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1 [0.84-1.19],0.989767103566351,trans
Chapter IX Diseases of the circulatory system,I9_IHD,SDC4,Syndecan-4,Inverse variance weighted,35,1 [0.91-1.09],0.99095291263701,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1 [0.78-1.29],0.991863959771671,trans
Chapter IX Diseases of the circulatory system,I9_IHD,CALCA,Calcitonin,Inverse variance weighted,13,1 [0.87-1.15],0.991940822200854,trans
Chapter IX Diseases of the circulatory system,I9_IHD,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1 [0.91-1.1],0.994072139071706,trans
Chapter IX Diseases of the circulatory system,I9_IHD,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1 [0.29-3.42],0.997382920405639,trans
